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Hrg1 and Mrp5 are identified as eukaryotic heme importer and exporter, 
respectively.  Two Hrg1 paralogs have been annotated in zebrafish genome, Hrg1a 
(Slc48a1b) and Hrg1b (Slc48a1a) with 84% homology in protein sequences.  Hrg1a 
and hrg1b are widely expressed in embryonic and adult zebrafish.  Yeast growth 
assays reveal that zebrafish Hrg1a and Hrg1b are both capable of heme import.  
However, hrg1a and hrg1b double knockout (hrg1 DKO) zebrafish generated by 
CRISPR/Cas9 has no overt defects in differentiation and maturation of erythroid 
cells.  Knockdown of hrg1a in hrg1b mutants or vice versa does not impair erythroid 
lineage in zebrafish embryos.  These genetic results suggest that Hrg1 is not required 
for maturation and hemoglobinization of primitive erythroid cells.   
Hrg1a and hrg1b mRNA are upregulated in adult kidneys and spleens upon 
PHZ-induced hemolysis, together with hmox1, a downstream heme degrading 
enzyme, suggesting that Hrg1 is involved in adult heme-iron recycling during 





iron staining reveals that iron is accumulated in macrophages in the kidney and spleen 
in adult wild-type zebrafish.  However, macrophages with positive Perl’s staining are 
rarely found in the kidney of hrg1 DKO and instead large amount of iron is deposited 
in renal tubules, suggesting defects in heme-iron recycling by kidney macrophages in 
hrg1 DKO under PHZ-induced hemolysis.  Whole transcriptome sequencing of 
mRNA extracted from spleens and kidneys reveals massive differentially expressed 
genes in hrg1 DKO involved in immune response, lipid transport, oxidation-reduction 
process and proteolysis.  These indicate that hrg1 DKO are deficient in recycling 
heme-iron derived from damaged RBCs in the absence of functional Hrg1.   
Phylogenetic analysis reveals that Mrp5 and Mrp9 are closed homologs in the 
zebrafish genome.  Yeast growth assays reveal that both zebrafish Mrp5 and Mrp9 are 
capable of heme export.  Morpholino knockdown of mrp5 and mrp9 in zebrafish 
showed severe anemia in developing embryos indicating their involvements in 
erythropoietic development.  Subsequent generation and characterization of mrp5 and 
mrp9 mutants by CRISPR/Cas9 will further define the function of Mrp5 and Mrp9 
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Chapter 1: Introduction 
 
Heme (iron-protoporphyrin IX) is an iron-containing porphyrin which can serve as a 
cofactor for various biological processes, such as oxygen transport, miRNA processing, 
electron transfer, and circadian clock control et al (1, 2).  Although iron is abundant on this 
planet, it is not readily bioavailable to humans, rendering iron deficiency anemia (IDA) as a 
common nutritional disorder (3).  Compared to inorganic  iron, heme is the most absorbable 
form of iron for human nutrition, highlighting the importance of understanding how heme is 
transported and utilized in our daily diet (4).  Moreover, human dietary iron only accounts for 
around 10 % of daily iron requirement which complements for daily iron losses, while the 
majority of iron supply comes from heme-iron recycling from clearance of senescent red 
blood cells (RBCs) (5, 6).  Therefore, iron absorption and heme-iron recycling contribute to 
systematic iron homeostasis.  One of the most evident symptoms for defects in iron transport 
and heme synthesis is anemia, which is due to aberrant production or function of RBCs in the 
circulating blood system (7).  RBCs contain approximately 70 % of overall iron inside the 
body, which makes it particularly important to maintain organismal iron homeostasis (7).  
Thus, understanding how heme is synthesized, trafficked and recycled may shed light on the 
pathology of anemia. 
 
Heme biosynthesis 
In most eukaryotes, heme is synthesized via a widely conserved eight-step pathway in 
cytosol and mitochondria requiring coordinated substrate transport between the mitochondria 
and cytosol (8).  The first step initiates in the mitochondrial matrix and is catalyzed by δ-
aminolevulinic acid synthase (ALAS) to synthesize δ-aminolevulinic acid (ALA) from 





to the cytosol for the following four enzymatic reaction steps: ALA to porphobilinogen 
(PBG) catalyzed by ALA dehydratase (ALAD); PBG to an unstable polymer 
hydroxymethylbilane by porphobilinogen deaminase (PBGD); hydroxymethylbilane to 
uroporphyrinogen III (UROgen III) by uroporphyrinogen synthase (UROS); and UROgen III 
to coproporphyrinogen III (CPgen III) by uroporphyrinogen decarboxylase (UROD).  CPgen 
III is then transported into the mitochondria where coproporphyrinogen oxidase (CPOX), a 
mitochondrial intermembrane space enzyme, catalyzes the formation of protoporphyrinogen 
IX (PPgen IX).  The inner mitochondrial membrane enzyme protoporphyrinogen oxidase 
(PPOX) catalyzes the formation of protoporphyrin IX (PPIX) from PPgen IX in the 
mitochondrial matrix.  On the last step, ferrochelatase (FECH) catalyzes the insertion of 
ferrous iron (Fe2+) into PPIX to form heme.   
 
Regulation of heme biosynthesis in RBCs 
Tremendous amount of heme is synthesized during differentiation and maturation of 
RBCs.  The efficiency of converting iron to heme in maturing erythroid cells is extremely 
high, resulting in heme-iron concentrations to be over 40,000-fold greater than non-heme iron 
in mature RBCs (9, 10).  One mode of tackling this large requirement for heme would be 
upregulating heme synthesis in mitochondria and then mobilizing heme out of the 
mitochondria for insertion into cytoplasmic globin to couple synthesis with increasing globin 
protein production.  In contrast, it is also essential to downregulate heme synthesis and 
decrease intracellular iron content when globin production is low in the early stage of 
erythropoietic development, since both free heme and iron are toxic to erythroid cells by 
inducing oxidative stresses.  Failure to regulate heme synthesis during erythropoiesis will 
cause either iron-deficient or iron-overload anemia (11). 
Although there are eight enzymatic steps for heme biosynthesis, the rate-limiting step is 





forms of ALAS exist, ALAS1 and ALAS2.  ALAS1 is ubiquitously expressed in all the 
tissues (13), while ALAS2 (or ALAS-E), is exclusively expressed in developing erythroid 
cells (14).  ALAS2 is activated by the transcription factor GATA1, a master regulator for 
erythropoiesis.  Chip-Seq analysis using G1E-ER4 erythroid progenitor cell line derived from 
Gata1 mutant mice identified two GATA-1 cis elements in the first and eighth introns of 
Alas2 (15–17).  Disruption of these two GATA1-binding elements abrogates expression of 
ALAS2 and subsequent inhibition of heme synthesis, which can be rescued by supplementing 
cells with high concentrations of ALA, the product of ALAS (16, 17).  Another regulation of 
ALAS2 occurs at post-transcription level, modulated by iron responsive elements (IREs) in 
the 5’UTR.  IREs interact with iron regulatory proteins (IRPs), linking the regulation of heme 
biosynthesis in erythroid cells to iron availability (18).  Under iron deficient conditions, IRPs 
bind to IREs and inhibit Alas2 mRNA translation.  Conversely, when intracellular iron level 
increases, IRPs are either degraded or converted to an aconitase by a [4Fe-4S] and Alas2 
mRNA translation resumes to promote heme synthesis.  The regulation of ALAS2 expression 
is coordinated with the cellular iron levels to tightly control cellular heme content.   
FECH is a second limiting enzyme in the heme biosynthetic pathway.  Transcription of 
Fech spikes during terminal erythroid differentiation and is controlled by the transcription 
factors SP1, NFE2 and GATA1(19).  Furthermore, the enzymatic activity of FECH is 
dependent on the presence of iron-sulfur cluster [4Fe–4S], again linking iron regulation to 
heme synthesis (20).  Distinct erythroid-specific elements have been identified in the 
promoter region of Fech, together with erythroid-specific alternate splicing in the 3′ 
noncoding region of Fech mRNA in the mouse genome (21, 22), further underscoring the 
unique regulatory mechanisms for heme synthesis in RBCs maturation.   
Beside regulation of heme synthesis in erythroid cells, globin synthesis is controlled by 
the Heme/BACH1 axis, in which heme binds to BACH1, a transcription suppressor, to 





coordinate the cellular iron level, heme synthesis, and globin protein expression, to maintain 
heme and iron homeostasis in erythroid cells.   
 
Iron acquisition during erythropoiesis 
The tremendous need for iron for heme synthesis during erythropoiesis mandates an 
efficient pathway to uptake extracellular iron.  Erythroid cells rely on a high affinity system 
composed of transferrin (Tf) and transferrin receptor (TFR).  One molecule of transferrin can 
bind to two ferric iron atoms with an association coefficient of  10-20 M at physiological pH 
(24).  Transferrin receptor 1 (TFR1, also known as CD71) tightly binds to TF, permitting 
developing erythroid cells to uptake iron efficiently from the circulation.  The complex of 
iron-bound TF and TFR1 is internalized by receptor-mediated endocytosis and the ferric iron 
is then released from TF as the endosomes acidify.  Since only ferrous iron can be utilized for 
erythropoietic heme synthesis, the released ferric iron is reduced to ferrous by STEAP3 (six-
transmembrane epithelial antigen of prostate 3 reductase) (25).  The ferrous iron is 
transported out of endosome by DMT1 (divalent metal transporter 1, also known as 
NRAMP2 and SLC11A2) (26). The apo-TF/TFR1 complex is then recycled back to the cell 
surface, where apo-TF dissociates from the TFR1 and re-enters the circulation.  The holo-
TF/TFR1 and apo-TF/TFR1 cycle ensures that erythroid cells optimize iron uptake from the 
circulation for maximal hemoglobin production.   
Non-TF iron uptake also exists in erythroid cells, although the overall evidence is not 
conclusive and postulated to be more relevant during pathological conditions of iron 
overload, when serum TF is saturated by iron (27).  By exposing erythroid cells to ferrous 
ammonium sulfate under in TF-free conditions, erythroid cells from all developmental stages 
can uptake non-TF iron and accumulate redox-active labile iron with generation of reactive 
oxygen species.  However, the utilization of non-TF iron for heme synthesis during 





may account for ineffective erythropoiesis of developing precursors in the bone marrow with 
shortened lifespan of mature RBCs in the circulation during iron-overload condition.  In vivo 
study of non-TF iron uptake by erythroid cells should be carried out to further delineate this 
pathway. 
Upon arrival in the cytosol, iron has to be either stored or further transported to the 
mitochondria for utilization, since free iron is cytotoxic due to Fenton chemistry (28).  Iron is 
stored in the cytosol by binding to ferritin with the aid of  Poly r(C)-binding protein (PCBP) 
(29).  PCBP1 and PCBP2 exhibit high affinity for ferritin in vitro and PCBP1 and its paralog 
PCBP2 co-immuoprecipitate with ferritin in HEK293 cells.  Co-expression of PCBP1 and 
PCBP2 together with human ferritins in yeast activates an iron deficiency response by 
increasing iron deposition into ferritin.  However, knockdown of PCBP1 but not PCBP2 
impaired iron utilization during RBCs maturation, and PCBP1 deficient mice show 
microcytic anemia (30). 
Iron storage has to be released before entering mitochondria for heme or iron-sulfur 
cluster synthesis.  While PCBP1 mediates delivery and integration of iron into ferritin, 
nuclear receptor coactivator 4 (NCOA4) promotes release of ferritin iron by directing ferritin 
to autophagosomes for protein degradation (30);  NCOA4 can be immunoprecipitated with 
erythroid ferritin.  Binding of PCBP1 precedes NCOA4-ferritin interaction, coinciding with 
globin synthesis during erythroid maturation.  NCOA4-deficient cells exhibit massive 
accumulation of iron in ferritin with impaired hemoglobinization and enhanced erythroid cell 
death by ferritinophagy, since ferritin is an essential source of iron for heme production 
during terminal erythroid differentiation. 
Upon release from ferritin, iron is then transported into mitochondria, which is 
mediated by SLC25A37 (mitoferrin1, MFRN1), a protein belonging to the family of 
mitochondrial solute carrier proteins.  MFRN1 is expressed in the inner mitochondrial 





derived from Mfrn1-dificient embryonic stem cells show a complete blockage of iron 
incorporation into heme.  Defect in Mfrn1 results in profound hypochromic anemia and 
erythroid maturation arrest owing to insufficient mitochondrial iron uptake in zebrafish.  
Deletion of two yeast Mfrn homologs, Mrs3 and Mrs4 impairs incorporation of iron into 
PPIX and formation of Fe-S cluster assembly, collectively resulting in poor growth under low 
iron conditions.  Deletion of Mfrn1 in mice is embryonic lethal and mice with targeted 
deletion of Mfrn1 in adult hematopoietic tissues show severe anemia owing to deficits in 
erythroblast formation (32). 
The majority of iron for heme synthesis in the mitochondria is acquired from the TF-
ferritin-MFRN axis in erythroid cells.  Alternate possible pathway of iron uptake by 
mitochondria was recently delineated as a “kiss and run” interaction between endosomes and 
mitochondria (33).  Three-dimensional direct stochastic optical reconstruction microscopy 
(dSTORM) revealed that transient interactions between iron-bound TF within endosomes and 
mitochondria are capable of directing iron into mitochondria in erythroid cells.  Tracing 
experiment with mitochondria-specific iron sensor RDA (rhodamine B-[(2, 2-bipyridin-4-yl) 
aminocarbonyl] benzyl ester) confirmed functional iron transfer from an interacting TF-
endosome to mitochondria.  The motility of TF-endosomes is significantly reduced upon 
encountering mitochondria, while blocking intra-endosomal iron release led to significantly 
increased motility of TF-endosomes and increased duration of endosome–mitochondria 






Regulation of iron uptake in RBCs 
The coordination between iron uptake, heme synthesis, and globin protein expression 
dictates a tightly regulated system during erythroid differentiation.  Like the regulation of the 
rate-limiting enzymatic step of ALAS2 during heme synthesis, the IRE/IRP system is also 
essential in controlling cellular iron uptake and storage via a posttranscriptional manner.  
Two IRPs has been identified, IRP1 and IRP2.  The binding of IRPs to IREs in 3’-UTR of 
Tfr1 mRNA increases the stability and strengthens the translation of TFR1, promoting 
cellular iron uptake.  IRPs can also bind to IREs situated in the 5’-UTR region of both H and 
L subunits of ferritin mRNAs to inhibit ferritin translation (34).   
Although IRPs can regulate cellular iron level by modulating mRNA translation or 
degradation, the IRE-binding activity of IRPs can be also inversely regulated by iron, 
representing a typical negative feedback in biological processes (18).  Both IRP1 and IRP2 
are ubiquitously expressed.  However, the mechanisms are distinct in controlling IRP1 and 
IRP2 activity in response to cellular iron pool.  The binding activity of IRP1 is negatively 
regulated by iron-sulfur cluster [4Fe-4S] insertion.  Under irons-replete condition, the binding 
of IRP1 to IREs is prevented by 4[Fe-S] cluster assembled into IRP1, which can decrease 
iron uptake by destabilizing TFR1 and enhancing ferritin translation for iron storage.  IRP2 
does not contain a Fe-S cluster and is regulated by iron via proteasome degradation, mediated 
by FBXL5 (F box and leucine-rich repeat protein 5) (35).  In summary, the regulation of the 
IRE-binding activities of IRP1 and IRP2 assures the appropriate expression of IRP targeted 







Figure 1.1 Iron metabolism in erythroid cells 
Iron acquisition in erythroid cells is dependent on endocytosis of Tf-bound Fe (Tf-Fe(III)) via 
the transferrin receptor (TFR1).  Iron (Fe(III)) is imported into the cytoplasm by DMT1 after 
reduction by STEAP3.  Pinocytosis of extracellular ferritin may also contribute to iron-uptake 
in erythroid cells.  Iron can be stored in the ferritin (FTL) (FTL-Iron) mediated by PCBP1 
and can be released from FTL promoted by NCOA4.  MFRN1 is responsible for bringing 
iron to the mitochondria for heme synthesis.  It is uncertain whether “kiss and run” direct iron 
transfer exists between lysosomes and the mitochondria.  Iron is inserted into PPIX by FECH 
to produce heme.  Iron is also used for Fe-S cluster synthesis with involvement of GLRX5.  
IRP1 binding can inhibit translation of ALAS2 to prevent the accumulation of toxic heme 
intermediates.  Cellular iron efflux is mediated by FPN and requires iron oxidation on the 





Heme as a regulator during erythropoiesis 
Heme itself can modulate gene expression by negatively regulating the transcriptional 
repressor BACH1.  Heme strongly stimulates transcription of heme oxygenase 1 (HO-1 or 
HMOX1), the enzyme which catalyzes heme degradation.  BACH1 represses HMOX1 gene 
expression by binding to multiple MAF recognition elements (MAREs) sites located within 
HMOX1 enhancers by forming heterodimers with another transcription factor MAF.  Under 
heme-replete condition, heme binding to heme regulatory motifs within BACH1 releases it 
from the enhancers. This allows binding of MAF-NRF2 or MAF-NFE2 heterodimers which 
function as transcriptional activators of HMOX1 (36).  Interestingly, Hmox1 mRNA 
decreases during erythroid differentiation of MEL cells, a murine erythroleukaemia cell line, 
while heme biosynthesis is upregulated to make sufficient quantities of hemoglobin (37).  
HMOX1 overexpression impairs hemoglobin synthesis, while HMOX1 deficiency enhances 
hemoglobinization in cultured erythroid cells (38).  Thus, HMOX1 can control the regulatory 
heme pool at appropriate levels for erythroid differentiation.   
MAREs can also be found in the enhancer of the L subunit of ferritin and globin locus 
control region (LCR) (23, 39).  Heme deficiency represses protein translation, especially 
globin synthesis, by activating heme regulated inhibitor (HRI), a stress protein kinase which 
phosphorylates eIF2a (40).  Phosphorylation of eIF2a prevents the exchange of GDP into 
GTP and inhibits globin mRNAs translation, ensuring globin production can be coordinated 
with heme synthesis during erythroid differentiation.  HRI deficient mice suffer from 
hyperchromic normocytic anemia with erythroid hyperplasia and erythrocytes are loaded with 









Mobilization of heme biosynthetic intermediates during erythropoiesis 
Although heme is an essential cofactor, the accumulation of free heme or its 
intermediates are cytotoxic (42).  Therefore, the synthesis and transport of these molecules 
must be tightly controlled and the time when the intermediates are processed and the location 
where the particular enzymes appear for catalytic reactions have to be coordinately regulated.   
ALA, product of ALAS from the first step of heme synthesis, has to be transported out 
of the mitochondria to be utilized by ALAD in the cytosol.  This transporter was recently 
identified to be mediated by SLC25A38, a putative glycine/ALA transporter (43).  Mutation 
in SLC25A38 results in mitochondria ALA deficiency and causes non-syndromic autosomal 
recessive congenital sideroblastic anemia (CSA).  Interestingly, mutations in slc25a38 in 
zebrafish causes phenotypes similar to CSA and the anemia phenotypes can be rescued by 
glycine together with folate, but surprisingly not ALA, questioning the direct role for 
SLC25A38 as an ALA transporter (44).   
ABCB6, a mitochondrial outer membrane ATP-dependent transporter, was proposed to 
mediate the transport of CPgen III from the cytosol to the mitochondria (45, 46).  However, a 
direct evidence of CPgen III transport by ABCB6 is lacking and the substrates transported by 
ABCB6 are still elusive.  Defects in ABCB6 is not associated with hematological defects 
(47).  ABCB6 is dispensable for erythropoiesis and localizes to the endosomal/lysosomal 
compartments and plasma membrane of erythrocytes rather than the mitochondria (48).   
 
The ins and outs of heme transport 
The hydrophobicity and cytotoxicity of free heme mandates the necessity of heme 
trafficking pathways (2).  The final step of heme biosynthetic pathway occurs in the inner 
mitochondria.  Thus heme must be exported out of the mitochondria for incorporation into 





Studies have shown that ABCB10 may facilitate transport of heme out of the 
mitochondria in erythroid cells (50).  ABCB10 is a mitochondrial ABC transporter located in 
the inner mitochondrial membrane.  ABCB10 interacts with MFRN1 and FECH and 
stabilizes the complex (51).  Expression of ABCB10 is highly induced during erythroid 
differentiation and ABCB10 overexpression strengthens hemoglobin synthesis in erythroid 
cells.  It has been shown that ABCB10-null mice display defective erythropoiesis and lack of 
hemoglobinized RBCs, indicating ABCB10 is essential for erythropoiesis in vivo (50).  
However, conclusive evidence for direct heme transport by ABCB10 is still lacking. 
The Feline leukemia virus subgroup C receptor-related protein 1 (FLVCR1) was 
identified as a heme exporter (52).  FLVCR1 belongs to the family of MFS (major facilitator 
superfamily) proteins which transport small solutes across membranes facilitated by a counter 
ion gradient.  Overexpression of FLVCR1 induces significant reduction in cellular heme 
content, suggesting that FLVCR1 is involved in heme export (52).  FLVCR1-null mice are 
embryonic lethal with deficiencies in definitive erythropoiesis, and suffer from craniofacial 
and limb deformities resembling those of patients with diamond-blackfan anemia (DBA).  
Flvcr1-/-  mice develop a severe macrocytic anemia with proerythroblast maturation arrest, 
suggesting that erythroid precursors may be exporting excess heme to avoid heme toxicity 
(53).   
Two isoforms of FLVCR has been identified, FLVCR1a and FLVCR1b.  While 
FLVCR1a encodes a plasma membrane-localized heme transporter, FLVCR1b was identified 
to be a mitochondrial isoform encoded from an alternative transcription start site, resulting in 
a shortened N-terminus containing a mitochondrial targeting signal (54).  Thus, FLVCR1a 
contributes to intercellular and FLVCR1b to intracellular heme transport.  FLVCR1a is 
expressed in different hematopoietic cells and shows weak expression in the fetal liver, 
pancreas and kidney (55).  Ectopically expressing FLVCR1a reduces intracellular heme level 





human hematopoietic K562 cells (52).  FLVCR1a may export heme during 
erythrophagocytosis (EP), a process in which macrophages phagocytose senescent RBCs, as 
FLVCR1a has been showed to interact with the extracellular heme-binding protein 
hemopexin and mediate heme export at least 100-fold more efficient in the presence of 
hemopexin (56).  FLVCR1a has a limited substrate range including heme, protoporphyrin IX 
and coproporphyrin, but not bilirubin, the product of heme catabolism.  FLVCR1a expression 
is increased during erythropoiesis and is at its greatest during intermediate stages of RBCs 
maturation when HMOX1 expression is low,  implying that FLVCR1a helps to maintain 
stoichiometric amounts of heme and globin by exporting excess heme and preventing heme 
toxicity to RBCs (57).  Depletion of FLVCR1b in HeLa cells results in accumulation of 
mitochondrial heme, indicating that FLVCR1b may play a role in heme export from the 
mitochondria (54).  Therefore, the embryonic lethality of FLVCR1 knockout mice may be 
due to lack of heme export from the mitochondria by FLVCR1b, as mice lacking FLVCR1a 
but not mitochondrial FLVCR1b appears to have normal erythropoiesis although with defects 
in erythroid maturation.  It is not yet known whether FLVCR1b resides on the inner or outer 
mitochondrial membrane.  Moreover, if mitochondrial heme export by FLVCR1b is 
indispensable and indeed attenuated in Flvcr1-/- mice, it cannot explain why embryos from 
Flvcr1-/- null mice can survive until E14.5.  Yeast does not appear to have an obvious FLVCR 
homolog, yet is able to export heme from the mitochondria indicating that alternate 
mechanisms must exist for mitochondrial heme export.   
ABCG2, also known as breast cancer resistance protein (BCRP) has been identified as 
a heme exporter in mammals (58).  ABCG2 is expressed in hematopoietic stem cells (HSCs) 
and erythroid progenitors.  Compared to high FLVCR1 expression during erythropoietic 
differentiation, the expression level of ABCG2 is particularly high at the early stages of 
hematopoiesis (59).  ABCG2 binds to heme directly through an extracellular loop 3 with a 





However, direct evidence that ABCG2 exports heme is still lacking (60).  Whether FLVCR1 
and ABCG2 can function synergistically to export heme during erythropoiesis is not clear.  
ABCG2-null human patients are defined as Jr(a–) blood group with a unique side population 
of HSCs, however, with no apparent deficiencies in erythropoiesis (61, 62). 
MRP-5 was identified as a heme exporter in Caenorhabditis elegans.  This roundworm 
is a unique model for uncovering unknown heme trafficking since it is a heme auxotroph but 
requires heme to grow.  Thus, it needs to acquire dietary heme via the intestine and distribute 
heme from the intestine to other tissues (63, 64).  C. elegans MRP-5 (CeMRP-5) localizes to 
the basolateral membrane of intestinal cells and loss of MRP-5 results in accumulation of 
ZnMP in intestinal cells and growth retardation.  Overexpression of CeMRP-5 and human 
MRP5 in yeast caused reduced growth owing to heme depletion, which could be rescued by 
co-expression of the heme importer, HRG-4.  Interestingly, overexpression of CeMRP-5 and 
human MPR5 causes heme levels to increase in the secretory pathway, as measured by a 
secretory pathway heme protein reporter.  However, the physiological role of MRP5 in 
vertebrates and it involvement in erythropoiesis is not clear. 
Heme carrier protein 1 (HCP1, SLC46A1) is a membrane protein expressed in 
enterocytes and was proposed to be an intestinal heme transporter (65).  However, subsequent 
studies revealed that HCP1 is a proton-coupled folate transporter (PCFT) rather than a heme 
transporter (66).  Erythroblasts from HCP1 knockout mice showed deficiency in 
differentiation and high apoptosis rate resulting in severe macrocytic normochromic anemia, 
which was ascribed to folate but not heme deficiency (67).  Moreover, knockdown of HCP1 
by shRNA in Caco-2 cells attenuated both heme and folate uptake but increased HO-1 
expression, suggesting HCP1 could potentially function as a low affinity heme importer (66, 
68) 
The Heme Responsive Gene -1 (HRG1, SLC48A1) was identified as a heme importer 





and CeHRG-6 were found in the C. elegans genome.  Significant heme-induced inward 
currents were observed in Xenopus oocytes injected with Cehrg-1, Cehrg-4, and human 
HRG1 mRNA, indicating heme-dependent transport across cell membranes (69).  Human 
HRG1 (SLC48A1) mRNA is abundant in the brain, kidney, heart, skeletal muscle, in addition 
to cell lines derived from duodenum and bone marrow (69).  HRG1 localizes to acidic 
endosomal and lysosomal organelles in HEK293 cells, and its binding affinity to heme 
increases as pH decreases.  Human HRG1 interacts with the C subunit of the vacuolar proton 
ATPase (V-ATPase) pump and enhances endosomal acidification (70).  These studies 
collectively suggest that HRG1 transports heme from the exoplasmic space or the lumen of 
acidic endosome–lysosomal compartments into the cytoplasm.  Global transcriptomic 
expression profiling shows that Hrg1 mRNA is expressed at increasing levels during 
erythroblast maturation (71).  Why a apparently heme importer would be necessary for 
erythropoiesis since developing RBCs are capable of iron-dependent de novo heme synthesis 







Figure 1.2 The ins and outs of heme transport 
Mitochondrial isoform FLVCR1b transports heme into the cytosol.  ABCB10 is reported to 
forms complex with FECH and MFRN1.  It is not clear whether ABCB10 transport heme.  
The cell surface FLVCR1a and the ABC transporter ABCG2 have been implicated in heme 
export.  MPR5 is a heme exporter which can transport heme from cytosol to the secretory 
pathway.  HCP1 is a folate importer as well as a low-affinity heme importer.  HRG-1 is a 
heme importer that localizes to endosomal/lysosomal compartments, but also traffics to the 








The dual play between erythroid cells and macrophages 
Although macrophages and erythroid cells represent different developmental lineages 
during hematopoiesis, namely myelopoiesis and erythropoiesis, erythroid cells maintain an 
intimate dual relationship with macrophages from birth to death (72, 73).  Adult definitive 
erythropoiesis is a tightly regulated process occurring in the bone marrow.  The development 
of erythroid cells initiates from differentiation of HSCs to burst- forming unit- erythroid 
(BFU-E) and then colony- forming unit- erythroid (CFU-E).  The CFU-Es continually 
develop in the following stages with different histological properties: proerythroblast, 
basophilic erythroblast, polychromatic erythroblast, orthochromatic erythroblast, reticulocyte 
and ultimately to mature RBCs in the peripheral blood (74).  This developmental process can 
be described as terminal erythroid maturation and takes place in a special microenvironment 
of the bone marrow called erythroblastic islands (EBI) (75).  The structure of EBIs was 
revealed as a structure of a macrophage (nurse macrophage) surrounded by developing and 
maturing erythroblasts.  The process of differentiation from proerythroblast to reticulocyte 
has been known to take place in EBIs (75).  Histological sectioning of bone marrow from 
mice has shown that roughly 10 erythroblasts were supported by central nurse macrophage, 
while this number is 5-30 for human EBIs (76, 77).  Not only in bone marrow, EBIs have also 
been found in the red pulp of the spleen and liver of mice, especially under stress conditions 
with extramedullary erythropoiesis (78).  Nurse macrophages play a critical role in 
enucleation of erythroblasts proceeding to the stage of reticulocytes (79).  For a long time, 
EBIs were thought to be only responsible for RBC maturation from definitive erythropoiesis.  
However, recent studies suggested that the development of primitive erythrocytes in yolk sac 
also involves similar structure as EBIs with central macrophages, and primitive RBCs are 
also enucleated with nuclear extrusion promoted by central macrophages to generate 





Macrophages promote erythropoiesis by directly stimulating proliferation and survival 
of erythroblasts.  Cultured erythroid precursors attached to macrophages are subjected to 
enhanced proliferation compared to non-attached erythroblasts, thereby suggesting that 
macrophages may augment the response to erythropoietic stimulation by direct interaction 
with erythroblasts (81).  Although the major iron source for developing erythroblasts is by 
uptake of TF-bound iron from circulation, nurse macrophages were proposed to support 
erythropoiesis by directly transferring ferritin bound iron to erythroid progenitors, a process 
called pinocytosis.  Cell culture studies have shown that extracellular ferritin is synthesized 
and secreted by macrophages, with capability of delivering iron to erythroblasts and 
supporting the differentiation of erythroid precursors in the absence of transferrin in the 
culture medium (82).   
Lifespan of mature RBCs is limited in circulation, with ~40 and ~120 days for mouse 
and human respectively (83, 84).  Circulating RBCs are also subject to damage in stressed 
conditions like hemolysis or some toxic effects to RBCs.  When RBCs become senescent or 
the number of damaged RBCs increases in the circulation, macrophages in the 
reticuloendothelial system (RES) (liver or spleen) contribute to clear the RBCs and promote 
iron recycling through EP.  The majority of iron required to sustain erythropoiesis is derived 
from recycled RBCs, and defects in EP lead to aberrant iron metabolism, including anemia 
and iron overload (72, 73).  Upon degradation of RBCs in erythrophagosome, heme must be 
imported into the cytoplasm for degradation by HMOX1.  Mice with HMOX1 deficiency lose 
the ability to recycle heme iron and consequently suffer from anemia, reduced serum iron, 
and accumulation of iron in the liver and spleen (85).  HMOX1 null mice lack liver and 
splenic red pulp macrophages and most pups die from heme-associated toxicity due to the 
inability to degrade heme from RBCs (86).  Heme extracted from hemoglobin during EP is 
reported to be degraded by HMOX1 inside the phagolysosome, and iron could then be 





membrane, for storage in ferritin or export into the circulation by ferroportin 1 (Fpn1) (87).  
However, there are several gaps existed in this model of heme-iron recycling.  First, HMOX1 
is embedded in the ER membrane via a transmembrane segment, with the enzymatic active 
site facing the cytosol (88, 89).  Second, the optimal pH for HMOX1 (pH 7.4) is closer to 
cytosolic pH than acidic lysosomal pH (90).  Third, maximal HMOX1 activity is achieved 
only in the presence of biliverdin reductase, which is located in the cytosol (89).  Moreover, 
immunocytochemistry studies suggest that HMOX1 is not found in or on the phagolysosome 
during EP (91).  These evidences collectively suggest that heme is transported out of the 
erythrophagosomes prior to degradation by HMOX1.  Indeed, HRG1 is recruited and 
colocalizes with NRAMP1 on the membrane of erythrophagosomes, surrounding ingested 
senescent RBCs in bone marrow derived macrophages (BMDMs) (91).  HRG1 is strongly 
expressed in macrophages of the RES and specifically localizes to the phagolysosomal 
membranes (92).  Expression of Hrg1 mRNA is upregulated during EP and depletion of 
HRG1 in mouse BMDMs causes defective heme transport from the phagolysosomal 
compartments and failure to upregulate of Hmox1 mRNA expression. These results suggest 
that HRG1 is a heme transporter for heme-iron recycling in macrophages, mobilizing heme 
from the erythrophagosome into the cytosol.  In vivo experiments reveal increased level of 
HRG1 in the spleen and liver of mice injected with phenylhydrazine (PHZ) with acute 
hemolysis and enhanced heme-iron recycling.   
While macrophages promote erythropoietic development by both supporting 
erythroblast maturation and clearing aged RBCs, RBCs can also affect macrophage 
differentiation in the RES.  It has been recently shown that stressed and senescent 
erythrocytes can transiently induce differentiation and propagation of monocytes to iron-
recycling macrophages on-demand in both liver and spleen (93).  The same effects also 
appear during hemolytic anemia, anemia of inflammation, and sickle cell disease with heme 





macrophages is possibly medicated by heme itself.  SPI-C, a transcription factor participates 
in a differentiation circuit for red pulp macrophages (RPMs) and BMDMs.  In Spic-/- mice, 
monocytes are unable to develop into RPMs resulting in iron overload in spleen, while other 
populations of monocytes and macrophages remain unchanged (94).  Interestingly, SPI-C 
expression was activated by heme itself, via release of heme-dependent transcription 
repressor BACH1 (95).  The heme/BACH1/SPI-C axis regulates the differentiation of 
monocytes into RES macrophages.  These evidences further justify the necessity for 
intercellular heme trafficking during development of RBCs and macrophages. 
  
Zebrafish erythropoiesis resembles those of higher vertebrates 
The teleost fish, Danio rerio, also known as zebrafish, has been under increasing 
attention as a model organism for studying vertebrate development owing to its advantage in 
developmental biology.  Adult zebrafish are relatively small and one breeding pair can 
produce 100-200 progenies per spawning each week, which allows easy maintenance of 
particular strains with small space and ensures production of numerous embryos for 
experiments (genetic screening work and building transgenic line).  The external fertilization 
and rapid development ex utero, combined with property of transparency, allow direct 
visualization and manipulation of developmental processes in early embryos, which are not 
possible in mice.  The techniques for transgenesis and gene manipulation are well developed 
in this model, rendering zebrafish as a genetically-tractable vertebrate animal model (96). 
Zebrafish has a similar hematopoietic program compared to higher vertebrates, 
spanning from developmental waves of hematopoiesis to conservation of producing 
comparable blood cell components.  Two successive waves of hematopoiesis, primitive and 
definitive, are also found in zebrafish (97, 98).  Additionally, crucial regulators have been 
isolated as orthologues of many essential mammalian hematopoietic regulators and functional 





identified mutants (99).  These conserved properties of zebrafish hematopoiesis make it a 
good model for hematopoietic study and its application to mammals. 
Primitive erythropoiesis in zebrafish occurs in the intermediate cell mass (ICM) of 
developing embryos, which is functionally equivalent to extra-embryonic yolk sac blood 
island region in mammals (100).  Primitive erythroid lineage arises from ICM previously 
developed from posterior lateral mesoderm (PLM) region.  Primitive erythropoiesis in 
zebrafish begins at the 4-somite stage with the appearance of expression of erythroid-specific 
transcription factor Gata1 (101).  Gata1, a zinc-finger transcription factor, serves as a 
determination factor for early primitive erythroid progenitors.  The circulating primitive 
erythroblast cells further proliferate and differentiate into mature erythrocytes through a 
series of morphological alterations, with elongated nucleus around 4 dpf (days post 
fertilization), and functionally survive to 10 dpf  in blood stream (102).  Mature erythrocytes 
display unique morphological characteristics distinguishable from adult counterparts by less 
cytoplasm and larger nucleus.   
Consistent with hematopoietic program in mammals, definitive hematopoiesis in 
zebrafish marks its distinctive wave by generating all blood cell lineages throughout the 
whole lifespan.  The initiation site of zebrafish definitive hematopoiesis has been identified 
by expression pattern of mammalian definitive hematopoietic regulator orthologues, C-MYB 
and RUNX1.  These two transcription factors dictate the formation of definitive HSPCs 
(hematopoietic stem/progenitor cells) in the AGM (aorta-gonad-mesonephros) region (103).  
In zebrafish, initial expression of runx1 and c-myb is located in the VDA (ventral wall of 
dorsal aorta) from 26-48 hpf (hours post fertilization), analogous to the AGM region in 
mammals, suggesting that definitive HSPCs are generated in the VDA.  The initiation of 
definitive hematopoiesis in VDA happens as early as 36 hpf (104).  At around 4-5 dpf , 
hematopoietic cells are identifiable in pronephros/kidney and thereafter by 13 dpf. The 





hematopoiesis throughout the lifespan (105).  Posterior blood island (PBI) also called caudal 
hematopoietic tissue (CHT), locates between the caudal artery and the caudal vein at the end 
of the tail, is recognized as a fetal hematopoietic organ in zebrafish, an intermediate 
hematopoietic site covering the period between VDA and kidney as a counterpart to fetal 
liver in mammals (106, 107).  Definitive erythrocytes are postulated to populate the 
circulation at around 5 dpf as RBCs emerge at this stage in bloodless mutants with defects in 
producing primitive erythropoiesis (108).  Transfusion experiments reveal that primitive 
erythrocytes are the major circulating erythroid components for the first 5 days and thereafter 
they are gradually replaced by presumptive definitive erythrocytes (102).  Like mammals, 
these definitive erythrocytes switch to express adult form of globins and could be 
discriminated morphologically from their primitive counterparts (109, 110).   
The kidney marrow (head kidney) is an adult hematopoietic organ in zebrafish which is 
functionally equivalent to BM in mammals.  Based on forward scatter (cell size) and side 
scatter (granularity), hematopoietic cells in the kidney marrow could be fractioned into four 
populations: immature precursors of all lineages, lymphoid cells, mature erythroid cells and 
myelo-monocytic cells (neutrophils, monocytes, macrophages, and eosinophils) (111).  
Transplantation rescue experiments by lethal irradiation in zebrafish reveals presence of 
definitive HSCs in the kidney marrow maintaining lifelong hematopoiesis program (112). 
Spleen is postulated to be another hematopoietic tissue in the adult zebrafish, although 
clear evidence is lacking to define its hematopoietic activity.  Compared to the kidney 
marrow, zebrafish spleen is not well characterized.  It was proposed that zebrafish spleen may 
function as a reservoir for RBCs where erythrocytes are stored and destroyed (113).  Splenic 
macrophages can be found in red pulp and contain phagosomes with erythrocytes and other 
cellular debris, indicating possible active EP in zebrafish spleen (114, 115).  However, the 
involvement of zebrafish spleen during heme-iron recycling is not well studied since studies 





Zebrafish as a model to study heme and iron metabolism 
Beside similar hematopoietic program, zebrafish genome largely resembles the human 
genome. The complete sequencing of the zebrafish genome makes it a powerful tool for gene 
discovery research and translates its findings to humans (116).  Large-scale forward genetic 
studies have been carried out in some invertebrate model organisms, particularly in the 
nematode and fruit fly.  However, it is extremely expensive to perform this approach in mice 
which is a vertebrate model most widely utilized to recapitulate in hematopoietic studies in 
humans.  Zebrafish was the first vertebrate organism established for large-scale forward 
genetic screening.  Chemical mutagenesis is achieved by exposing adult male fish to N-ethyl-
N-nitrosourea (ENU) for several days which induces point mutations in the spermatogonia.  
These male fish are then mated with wild type (WT) female fish to propagate the mutation to 
F1 progenies (99, 117).  Screening methods such as antibody staining, whole mount in situ 
hybridization (WISH) and behavioral analysis can be then used to identify morphological or 
genetic phenotypes.  By contrast, gene-specific knockdown mediated by morpholino-
injection serves as an efficient tool for reverse genetic study (118).  Mutagenesis and targeted 
gene disruption have contributed to uncovering the genes involved in heme and iron 
metabolism in zebrafish.  Recent development of gene-editing tools such as TALENs and 
CRISPR/cas9 for targeted gene disruption complement transient morpholino gene 
knockdown for reverse genetic studies (119, 120).  Several key genes which are involved in 
heme synthesis and metabolism have been elucidated in zebrafish by both forward and 
reverse genetic manipulation. 
 
ALAS2 
Alas2 is the erythroid-specific enzyme for heme synthesis, while Alas1 is found in all 





and positional cloning revealed that sau contains mutation in alas2 (121).  The sau mutants 
have a microcytic, hypochromic anemia, delayed erythroid maturation, and abnormal globin 
gene expression, suggesting that defects in heme synthesis can affect globin protein 
production.  Interestingly, sau mutants have normal RBC number, and show anemia around 
33 hpf. Perhaps maternal heme my permit early RBC development or that the alas2 mutation 
is hypomorphic.  As mutations in alas2 cause CSA in humans, sau represents the first animal 
model of this disease in zebrafish (121).  Most interestingly, sau zebrafish mutants are viable 
even though it has only one-tenth of overall heme content compared to WT zebrafish.  Sau 
mutants can be fully rescued by supplementing developing embryos with ALA, which may 
further enhanced its value as a model to study the pathology of CSA in humans (122). 
 
ALAD 
Unlike ALAS, only one form of ALAD was found in both human and zebrafish.  So 
far, no mutation in alad has been identified in zebrafish.  However, an alad mutant (who) was 
identified in medaka, another teleost fish model (123).  Who mutants suffer from 
hypochromic anemia, owing to deficiency in heme synthesis.  Initial blood cell number is 
normal, but it then gradually decreases during the embryonic and larval stages.  The RBCs 
develop an elongated, occasionally curved morphology, possibly caused by accumulated 
globin protein without heme, representing sickle-cell anemia in humans with globin protein 
aggregations (124).   
 
UROD 
Zebrafish mutant yqe embeds a nonsense mutation in the gene encoding UROD, which 
converts uroporphyrinogen to coproporphyrinogen.  Homozygous mutation in urod leads to 





(HEP) in human, similar to the phenotypes in zebrafish with photosensitive porphyria 
syndrome (125).  Excessive amounts of uroporphyrinogens and 7-carboxylate porphyrin 
accumulate in yqe embryos, representing human HEP patients characterized by 
photosensitive skin and excessive excretion of heme biosynthesis intermediates, uroporphyrin 
and 7-decarboxylate porphyrin in their urine.  The zebrafish yqe mutant phenocopies human 
patients facilitating studying of HEP pathogenesis and development of new therapeutics. 
 
PPOX 
Zebrafish porphyria mutant, montalcino (mno), contains mutation in ppox, which 
catalyzes the oxidation of protoporphyrinogen, representing human variegate porphyria.  
Initially, at the onset of circulation, mno displays normal numbers of RBCs but are o-
dianisidine negative.  A visible decrease in circulating erythrocytes can be observed after 36 
hpf and the RBCs in the mutant embryos are epifluorescent.  The mno mutant zebrafish could 
survive to approximately 25 dpf.  Accordingly, human PPOX could partially rescue the 
hypochromia in homozygous mutants, revealing functional conservation.  The zebrafish mno 
mutant will be very useful for further elucidating the pathophysiology of variegate porphyria 
and identifying chemical modifiers of this disease. 
 
FECH 
Two different mutant alleles of fech have been identified in zebrafish, freixenet (frx) 
and dracula (drc) (99, 126).  Protoporphyrin IX accumulates in fech mutant embryos owing 
to a deficiency in the activity of ferrochelatase, the terminal enzyme in the pathway for heme 
biosynthesis.  The mutants show light-dependent hemolysis and liver diseases, similar to that 







Phenotypic analysis of shiraz (sir) mutant zebrafish revealed an intimate connection 
between heme biosynthesis and [4Fe-4S] formation, connecting two main uses for iron in the 
mitochondria, usually thought to be independent processes (127).  In sir mutants, 
hypochromic anemia, in the context of normal mitochondrial iron and oxidative stress levels, 
was shown to be caused by a deletion in the glutaredoxin 5 (grx5) gene.  GRX5 is required 
for the synthesis of Fe-S clusters in mitochondria (128). The zebrafish protein also localizes 
to the mitochondria and is capable of rescuing grx5-deficient yeast strain.  Fe-S clusters are 
known to negatively regulate binding of IRP1 to IREs.  Decreased Fe-S cluster assembly in 
sir mutant leads to increased IRP1 activity, which inhibits the expression of IRE-regulated 
target genes involved in heme biosynthesis like alas2.  Indeed, alas2 expression is absent in 
sir mutant.  Deletion of IREs in the alas2 mRNA rescued the anemic phenotype while 
overexpression of full-length alas2 mRNA did not, suggesting that the function of GRX5 in 
regulating ALAS2 expression is through Fe-S clusters and IRP/IRE activity.  An evolutionary 
conserved role for GRX5 in regulating heme synthesis was confirmed in human patients with 
GRX5 mutation (129).   
 
MFRN1 
Two mitoferrin homologs are found in the zebrafish genome, Mfrn1 and Mfrn2.  
Positional cloning of frascati (frs) zebrafish mutants identified a missense mutation in the 
mfrn1 (slc25A37) gene, an erythroid specific form (31).  Frs mutants develop hypochromic 
anemia and arrested erythroid maturation.  Mouse Mfrn1 rescues the phenotypes in zebrafish 
frs mutants.  The same anemic phenotype was observed in a mouse model with Mfrn1-
knockout (32, 130).  The MFRN2 (Slc25A28) paralog functions in mitochondrial iron import 







DMT1 was first isolated in the rat duodenum and is upregulated by dietary iron 
deficiency, while Belgrade rat with mutation in dmt1 suffer from iron deficient anemia (26, 
131).  Zebrafish mutants chardonnay (cdy) carry a nonsense mutation in dmt1 with reduced 
hemoglobin levels and delayed erythrocyte maturation (132).  The Dmt1 protein localizes to 
erythroid cells and the intestine, suggesting its role in intestinal and erythropoietic iron 
absorption.  Cells with overexpression of WT zebrafish Dmt1 uptake nearly ten times the 
amount of iron as non-transfected control cells, whereas the cdy mutant form is not 
functional.  However, cdy mutant can survive to adulthood irrespective of severe anemia, 
suggesting alternative pathway for iron absorption in zebrafish.  In humans, mutations in 
DMT1 cause a phenotype of hypochromic microcytic anemia combined with iron overload, 
further supporting possible existence of alternative iron absorption mechanisms in the 
duodenum that bypasses DMT1 (133). 
 
FPN1 
The first identified iron exporter Fpn1 (Slc40A1) was found by position cloning of 
zebrafish weissherbst (weh) mutant (134).  Weh mutant embryos suffer from hypochromic 
anemia, as evidence from decreased hemoglobin levels, blocked erythroid maturation, and 
reduced numbers of erythrocytes.  Erythroid cells of mutant embryos have significantly lower 
iron concentration compared to WT embryos, suggesting iron deficiency in mutants.  
Microinjection of iron-dextran rescued the anemic phenotype of weh mutants and continuing 
injection of iron-dextran also rescued embryonic lethality.  However, these rescued fish are 
only normal until six months of age and eventually develop hypochromic anemia by 12 





Compared with iron injected WT fish, the rescued mutants had increased iron staining in 
kidney macrophages, as well as increased staining in intestinal villi, suggesting that fpn1 
mutation impairs iron export in these tissues.  The iron-rescued weh mutants also have 
hepatic iron overload, with particularly high iron levels in the liver küpffer cells (135).  FPN1 
also localizes to the yolk-syncytial layer (YSL) during embryonic development, suggesting 
that FPN1 may transport maternal iron from the yolk for embryogenesis.  Both mice and 
humans have homologs of FPN1with high similarities to zebrafish Fpn1.  Mammalian FPN1 
is robustly expressed in the placenta, duodenum, and liver.  At the protein level, human FPN1 
is concentrated on the basal surface of the syncytiotrophoblast in the placenta, an organ that is 
functionally similar to zebrafish YSL, indicating that human FPN1 plays a role in maternal-
fetal iron export.  In mice, FPN1 is expressed on the basolateral surface of enterocytes, 
suggesting a role in intestinal iron transport (136). 
 
TF 
The zebrafish mutant gavi (gav) was shown to have mutations in transferrin-a (Tf-a), 
which encodes the principal serum iron carrier (137).  Gav mutant embryos exhibit reduced 
tf-a expression and impaired hemoglobin production with hypochromic anemia and 
embryonic lethality by 14 dpf.  In humans, phenotype of congenital hypotransferrinemia 
caused by TF mutation is highly similar to those of gav mutants, including hypochromic 
anemia and embryonic death (138).  The gav mutant is thus an ideal whole vertebrate anemia 
model for studying symptoms corresponding to human pathologies related to Tf.   
 
TFR1 
Transferrin-bound iron is taken up into cells by binding to the transferrin receptor 1 





anemia and defective erythroid differentiation were ascribed to mutations in tfr1a gene (139).  
During early development, tfr1a transcripts are expressed specifically in erythrocytes.  
Importantly, cytoplasmic delivery of iron by microinjection at one-cell stage—but not 
intravenous iron injections can rescue the hypochromia phenotypes of cia mutants, indicating 
that tfr1a mutation prevents erythrocytes from taking up and utilizing circulating iron.  
Intriguingly, a second tfr1 gene, tfr1b was identified together with tfr1a, a typical feature in 
zebrafish genome which has undergone genome duplication (140, 141).  Whereas Tfr1a is 
expressed in erythrocytes during early development and cia mutants are anemic, Tfr1b is 
expressed ubiquitously throughout embryogenesis and knockdown of tfr1b by morpholinos 
do not affect hemoglobinization.  Tfr1b morphants have retarded growth and develop brain 
necrosis, a phenotype that is similar to the neurologic defects observed in the mouse model 
(142), indicating that tfr1b may be involved in iron uptake in non-erythroid tissues.  Tfr1a 
(cia) and tfr1b deficient zebrafish embryos recapitulate the phenotype of TFR1-/- mice (140, 
141).   
 
FLVCR 
Currently no zebrafish mutants have been reported with perturbation of Flvcr.  
However, the function of zebrafish Flvcr is related to erythroid differentiation and maturation 
(143).  Two splicing isoforms have been identified: flvcr1a and flvcr1b.  Flvcr1a is required 
for the expansion of committed erythroid progenitors but cannot drive their terminal 
differentiation, while Flvcr1b contributes to the expansion phase and is required for 
differentiation (143).  The coordinated expression of Flvcr1a and Flvcr1b contributes to 
controlling the cytosolic heme pool required to sustain regulation of erythroid progenitors and 
hemoglobin synthesis for hemoglobinization during terminal maturation.  Interestingly, 
treatment of succinylacetone (SA), an inhibitor of heme synthesis at ALAD enzymatic step, 





hemoglobinzation of flvcr1b morphants, suggesting that intracellular heme pool during 
erythropoiesis is tightly regulated. 
 
Problem statement 
The current tenet dictates that erythroblasts are self-sufficient, i.e. they produce large 
amounts of hemoglobin by simply upregulating endogenous heme synthesis.  However, this 
is puzzling since erythroblasts also express FLVCR1a, a heme exporter.  Loss of FLVCR1a 
expression cause the apoptosis of proerythroblast owing to heme toxicity (144).  Why do 
maturing erythroblasts need to export heme, since they will need large amounts of heme for 
hemoglobin synthesis? A recent study showed that coordinated expression of heme synthesis 
and globin protein is essential for effective erythropoiesis (145).  Erythropoiesis failure 
occurs in flvcr-null mice at the CFU-E/proerythroblast stage, a point at which the transferrin 
receptor (CD71) is upregulated to maximize iron import for heme synthesis.  However, at this 
time point, erythroid progenitors contain excess heme over globin production.  This excess 
heme can cause increased cytoplasmic ROS resulting in increased apoptosis in the absence of 
heme exporter FLVCR1a.  By contrast, terminal erythroid maturation includes a coordinated 
loss of intracellular organelles including the mitochondria, the site for heme synthesis.  
However, hemoglobin production continues as erythroid cell mature, requiring heme even 
though the cells lack proper mitochondria function.  At this stage, globin synthesis exceeds 
heme synthesis.  We propose that heme uptake at this stage could compensate to reset the 
stoichiometry between globin and cellular heme levels. 
HRG-1 is a heme importer initially identified using C.elegans as an animal model, with 
orthologs in many higher vertebrates (69).  Global transcriptome analysis shows that hrg1 
mRNA increases during mouse terminal erythroid maturation (146).  This is puzzling because 
it is unclear why HRG1would be regulated in erythroid precursors.  We postulate that during 





production as intracellular heme synthesis may be insufficient to cope with globin production.  
In this regard, erythroid precursors likely behave like C. elegans, a heme auxotroph, that 
acquire and utilize exogenous heme.  What could be the source of this additional heme?  It is 
possible that a portion of heme and/or iron within maturing RBCs is derived from inter-
cellular transport from nurse macrophages in EBIs to support the terminal stages of 
hemoglobinization, especially under conditions such as stressed erythropoiesis while heme 
synthesis is insufficient.  In support of this hypothesis, heme importers (HRG1) are expressed 
in both red blood cells and macrophages.  While this might be plausible for definitive 
erythropoiesis, what about primitive erythropoiesis?  In situ hybridization reveals clear 
expression of mouse hrg1 in placenta and trophoblast cells, primitive and definitive erythroid 
cells [since they make up the vast majority of the cells in yolk sac blood islands/ blood 
vessels (E7.5-E8.5/E9.5; primitive lineage)], E12.5 fetal liver (definitive lineage), and 
developing neural tissues.  These results support a model in which inter-tissue and inter-
cellular heme transport must occur during development and maternal HRG1 may be essential 
for mobilizing pre-existing heme stores in oocytes for early embryonic development and 
primitive erythropoiesis.  To elucidate the heme trafficking during erythropoiesis, I exploited 
zebrafish as a whole vertebrate animal model to uncover the possible mechanisms of 






Chapter 2: Materials and Methods 
Zebrafish methods 
Zebrafish husbandry 
All zebrafish procedures were approved by University of Maryland Animal Care and 
Use Committee.  All used zebrafish embryos and lines were kept within the zebrafish facility 
(Aquatic Habitats, USA) in Department of Animal and Avian Sciences, University of 
Maryland College Park.  The fish water is kept at 28 °C, conductivity ~1000, stable pH value 
between 7.3~7.4.  The light providing cycle is maintained around 10 h light off (9:30 pm ~ 
7:30 am) and 14 h light on.   
To generate embryos, male fish was bred to female fish by putting them together in a 
tank with an inner nested mesh overnight and embryos were collected next morning.  To 
make fish spawning for a controlled time point (e.g.  micro-injection or collecting embryos of 
relatively synchronized developmental stages), a transparent divider was placed in the middle 
of tank to separate male and female.  Embryos were obtained once the divider was removed 
at the following morning.  Embryos were kept in embryo medium prepared as described in 
The zebrafish book (4th) (147).  To keep the embryos transparent at early stages, 0.003 % 
PTU was added around 18-24 hpf.  Zebrafish strain Tü were used as WT throughout this 
study. 
 
Microinjection of zebrafish embryos 
The injection needles were made from capillaries with internal filaments (BF100-58-
10, Sutter Instrument, Novato, CA) on needle puller (P-97, Sutter Instrument, Novato, CA).  
The pulling parameter was empirically determined.  A commonly used set of parameter was 
as follows: Heat (574) Pull (110) Velocity (50) Time (140).  The needles were further broken 





To carry out the microinjection, embryos were held in wedge-shaped mold made by 
1.5 % Agarose in Petri dish.  For injection of DNA constructs or mRNA, embryos were 
oriented with animal poles of embryos opposite to injection needle.  Injection solutions were 
backfilled into needle with microloader (Eppendorf, Hamburg, Germany).  Injections were 
performed on the stage of Nikon stereomicroscope equipped with manipulator (Harvard 
Apparatus, Holliston, MA) and injector (World Precision Instrument, Sarasota, FL).  Usually, 
around 1.4 nL solution was injected into a single embryo without affecting normal 
development. 
 
Morpholino-mediated gene knockdown  
Morpholinos were designed and synthesized by GeneTools (Philomath, OR).  
Translation- and splice-blocking morpholinos were designed to block mRNA translation and 
pre-mRNA splicing, respectively.  Morpholinos were delivered to one-cell staged embryos by 
microinjection as described above.  The sequences of morpholinos were listed in Appendix I. 
 
In vitro transcription 
The in vitro transcription was used to generate digoxigenin (DIG)-labeled RNA probe 
for WISH and cRNA (capped RNA) for microinjection to fish embryos.   
For WISH, fragments were PCR amplified and then subcloned into distinct plasmids.  
To make DIG labeled anti-sense RNA probe, plasmid DNA was first linearized by 
appropriate restriction enzyme and purified using DNA purification kit (Machinery-Nagel, 
Germany).  The purified linearized DNA was then used as a template for in vitro transcription 





For generation of cRNA for injection, plasmid DNA with the specific fragments of 
interest was linearized, gel-purified and used for in-vitro transcription according to the 
manuals of mMESSAGE mMACHINE T7/T3/SP6 Transcription Kit (Thermo Fisher). 
 
Whole-amount in situ hybridization 
Whole amount in situ hybridization was perform as described (148).  Briefly, embryos 
were dechorinated either manually or by 1 µg/ml pronase (Roche, Mannheim, Germany).  
The dechorinated embryos were then fixed in 4 % paraformaldehyde (PFA) in PBS at 4 °C 
overnight or room temperature (RT) for 2 h.  Following fixation, embryos were rinsed with 
PBST (PBS plus 0.1 % Tween 20) for 2 × 5 min.  Embryos were then dehydrated in 50 % 
methanol (MeOH)/PBST for 5 min and 100 % MeOH for 5 min before storage in fresh 
MeOH at RT.  Embryos were sequentially rehydrated with 75 % MeOH/PBST for 5 min, 
50 % MeOH/PBST for 5 min, 25 % MeOH/PBST for 5 min, and PBST, 4 × 3 min.  Embryos 
were treated with 10 μg/mL proteinase K in PBS for permeabilization as periods described 
(148).  After permeabilization, embryos were re-fixed with 4 % PFA for at least 20 min 
followed by PBST wash for 4 × 3 min.  Subsequently embryos were incubated with 
hybridization buffer (HB) buffer for 5 min at 65 °C before changing to new HB buffer for 
prehybridization for 1 h at 65 °C.  Following prehybridization, embryos were hybridized with 
denatured DIG-labeled anti-sense RNA probe at 65 °C for overnight.  The following day, 
embryos were sequentially washed with HB/2 × SSCT (1:1) at 65 °C for 2 × 30 min, 2 × 
SSCT, 0.2 × SSCT at 65 °C for 2 × 30 min and PBST at RT for 4 × 3 min.  After extensive 
wash, embryos were pre-incubated with blocking solution made with 2 % lamb serum + 2 % 
BSA in PBST for 1 h followed by incubation in antibody solution (Anti-Dig alkaline 
phosphatase (AP) (Roche) 1:4000 diluted in blocking solution) at RT for 2 h or 4 °C 
overnight.  Afterwards, embryos were washed with PBST for 6 × 20 min in order to remove 





50 mM MgCl2, 100 mM NaCl, 0.1 % Tween20, pH 9.5) for 2 × 10 min.  The signals were 
developed by incubating embryos with NBT/BCIP (nitroblue tetrazolium / 5-bromo-3-chloro-
3-indolyl phosphate) tablet (Roche). 
 
Zebrafish tissue dissection 
Dissection of various adult zebrafish tissue was performed as previously described 
(149).  For RT-PCR experiments, dissected tissues were immediately placed in TRIzol 
(Invitrogen) and flash frozen in liquid nitrogen before RNA extraction.  For membrane 
fractionation, tissues were directly flash frozen before fractionation. 
 
Generating of zebrafish mutants by TALEN and CRISPR/Cas9 gene-editing 
TALEN targeting vectors were cloned and generated by Golden Gate serial ligation as 
described (150).  The TALEN target sites were selected in silico at TAL Effector Nucleotide 
Targeter 2.0 (https://tale-nt.cac.cornell.edu/) with hrg1a ORF sequence (NCBI accession No.: 
NM_200006.1).  The pcGoldy-TALEN targeting constructs were generated according to the 
selected sequence.  The plasmids were linearized by restriction enzyme digestion and then 
gel-purified.  Linearized plasmid (1 µg) was used for in-vitro transcription to produce capped 
TALEN mRNA.  Equimolar of TALEN mRNA (300 ng) pair was used for microinjection.   
The CRISPR gRNA was designed using Optimized CRISPR Design 
(http://crispr.mit.edu/).  The gRNA target sequences were in silico predicted using hrg1a 
(NM_200006.1) and hrg1b (NM_001002424.2) ORFs as inputs.  The gRNA constructs were 
cloned using pT7-gRNA as backbone (120).  pCS2-Cas9 was used to produce Cas9 cRNA 
after linearization and in-vitro transcription.  Cas9 cRNA (300ng) and gRNA (100ng) was co-





Both TLAEN and CRIPSR-injected embryos were raised to adulthood as F0 founders.  
The founders were subjected to tail-clip genotyping to confirm indels at target sites.  Positive 
chimeric F0 founders were them crossed to WT zebrafish to generate F1 offsprings.  The F1 
embryos with indels at target sites were raised to adulthood for genotyping and screening for 
stable mutant lines.   
 
Zebrafish mutant genotyping 
For genotyping of adult zebrafish, a small piece of tail was clipped and placed in 50 µl 
50 mM NaOH at 95 °C for 30 min.  For genotyping of embryos, either whole embryos or 
clipped small piece of tail from 3 dpf embryos were dissolved in 10 ul of 50 mM NaOH at 
95 °C for 30 min (151).  The solution was vortexed to completely dissolve the tail.  One tenth 
volume of 1 M Tris-HCl at pH 8.0 was added to neutralize the solution.  One microliter of 




Total RNA was extracted from whole zebrafish embryos or from dissected tissues 
using TRIzol.  Pooled embryos (20~30 for each) were placed in TRIzol and RNA was 
extracted accordingly.  After resuspension in RNase-free water, total RNA was further 
digested by RNAase-free DNase (Ambion), to get rid of genomic DNA, followed by 
isopropanol/sodium acetate precipitation. 
 
RT-PCR  
Total RNA (1 µg) was used for reverse transcription by iScript cDNA synthesis kit 





cDNA was diluted 2-5 times for following PCR reaction.  To relatively quantify gene 
expression, RT-PCR of cDNA samples was performed by limited 25 PCR amplification 
cycles.  Quantitative RT-PCR (qRT-PCR) was done with SsoAdvanced Universal SYBR 
Green Supermix (Bio-Rad).  Each reaction was technically triplicated. 
 
O-dianisidine staining 
O-dianisidine staining was performed to detect hemoglobin in RBCs of whole embryos 
as previously described (152).  The principle for this assay is that heme in hemoglobin 
catalyzes oxidation of o-dianisidine in the presence of H2O2, producing a dark brown color in 
hemoglobin-positive cells.  Briefly, collected embryos were placed in 1 ml staining solution 
(0.06 % (w/v) o-dianisidine, 25 % ethanol, 10 mM Sodium Acetate and 0.02 % H2O2) for 20 
min in the dark.  Staining was stopped by rinsing embryos with 70 % ethanol.  Embryos were 
post-fixed in 4 % formaldehyde in PBS and stored in 50 % glycerol in PBS for microscopy. 
 
DAB enhanced Perl’s iron staining in zebrafish 
Perl’s Prussian blue stain was performed to detect ferric iron in whole zebrafish 
embryos and zebrafish sections (153).  Embryos were fixed by 4 % PFA at RT for 2 h and 
were immersed in a freshly prepared staining solution (2.5 % potassium ferrocyanide, 0.25 M 
HCl) for 30 min at RT, then rinsed three times in PBST.  To prepare stain enhancement, 
endogenous peroxidase activity was quenched by incubating embryos in 0.3 % H2O2 (in 
methanol) for 20 min at RT.  Following rinse in PBST, embryos were incubated for 7 min in 
SigmaFast DAB tablet (Sigma-Aldrich) dissolved in distilled water.  Ferric ferrocyanide 
catalyzes the H2O2-mediated oxidation of DAB, producing a reddish brown color.  Embryos 






FACS cell sorting 
The embryos from globinLCR: GFP line (crossed with hrg1a or hrg1b mutant line or 
morpholino-injected embryos) were pooled and harvested.  The cells were disaggregated with 
0.25 % trypsin (154), and were then sequentially filtered through 70 µm and 40 µm cell 
strainers.  The percentage of GFP-positive cells in transgenic embryos were analyzed by 
FACSCanto II machine (BD Biosciences) (155). 
 
Membrane fractionation 
Dechorinated zebrafish embryos or dissected adult tissues were homogenized by 
Dounce Homogenizer in appropriate volume of homogenization buffer (10 mM Tris-HCl, 
mM EDTA, 1 mM PMSF, protease inhibitor cocktail (Roche)).  The homogenized solution 
was then centrifuged at 800 g 4 °C for 5 min.  Then the supernatant was ultra-centrifuged at 
100, 000 g 4 °C for 90 min with XL90 ultracentrifuge (Beckman, Germany).  The supernatant 
was considered as the cytosolic fraction and the pellet was treated as the total membrane 
fraction.  The pellet was collected and dissolved in lysis buffer (2 % triton-x100, 150 mM 
NaCl, 50 mM Tris-HCl, 20 mM HEPES, 1 mM PMSF, 1 mM EDTA, 1X protease inhibitor 
cocktail).  The membrane lysate was used for the following immunoblotting experiments. 
 
Immunblotting 
HRG1 antibody serum was generated in rabbits using the 17 amino acid peptide 
sequence (YAHRYRADFADIILSDF) from c-terminus of human HRG1 as the immunogen 
(Thermo Fisher).  Since the C-terminal 17 amino acid sequence of human HRG1 is highly 
conserved with zebrafish Hrg1a and Hrg1b (15/17), it cross-reacts well with both Hrg1a and 
Hrg1b.   





lysate was measured using the Pierce BCA assay kit (Thermo Scientific).  Equal amount of 
total protein was mixed with Laemmli sample buffer and were separated on 12 % SDS-PAGE 
and transferred to a 45 µM nitrocellulose membrane using the semi-dry transfer apparatus 
(Bio-Rad).  The affinity purified Hrg1 primary antibody was used at a concentration of 
1:1000; goat anti-rabbit HRP-conjugated secondary was used at 1:30,000, and blots were 
developed with the SuperWest Femto Chemiluminescent Substrate (Thermo Scientific). 
 
Collection of Embryonic RBCs 
Zebrafish were firstly anesthetized in few drops of tricaine solution: 0.02 % tricaine 
(Sigma-Aldrich), 1 % bovine serum albumin (BSA) in calcium- and magnesium-free PBS 
(pH 7.4).  For each sample, tails of approximate ten zebrafsih were cut by either a blade or 
surgical scissor to allow RBCs to flow into the tricaine solution.  The tricaine solution 
containing RBCs was loaded into Shandon EZ Single Cytofunnels (Thermal scientific) and 
RBCs were concentrated onto a superfrost slide (Thermal scientific) by centrifugation at 450 
rpm for 3 min using a Shandon Cytospin® 4 cytocentrifuge (Thermal scientific) according to 
the manufactory’s instruction.  Slides were air-dried prior to May-Grünwald Giemsa staining. 
 
Collection of adult circulating blood 
Adult fish were placed in fish water with 0.02 % tricaine for anesthesia.  Under a 
stereoscope, use a micro-capillary was used to punctuate in caudal vein around the fish tail.  
The blood was allowed to back-fill into the heparinized capillary.  A maximum 1-2 µl of 
blood could be collected from each adult zebrafish.  The collected blood was placed in PBS 
and centrifuged, then smeared on charged slides for further staining.   
 





May-Grünwald staining solution (May-Grünwald solution (MG500, sigma-aldrich) : 
methanol= 1:3) was gently added onto slides containing RBCs covering area and incubated at 
RT for 5 min and then gently washed off with double distilled water.  Subsequently, the 
slides were incubated with 1 ml Giemsa staining solution (Giemsa Stain (GS500, Sigma-
Aldrich) : water = 1:20) for 15-30 min.  The Giemsa staining solution was then washed off 
with water and slides were air-dried before examining under microscope. 
 
Phenylhydrazine (PHZ) treatment 
To induce acute hemolysis at the embryonic stages, 4 dpf embryos were put in embryo 
medium with 1 µg/ml PHZ (pH 7.4) for 1 h.  PHZ was then removed and embryos were 
rinsed three times with fresh embryo medium.  For PHZ treatment in adult fish, 2.5 µg/ml 
PHZ was prepared in system fish water.  The adult fish was placed in fish water with PHZ for 
25 min at 28°C.  PHZ was removed by three time rinse with fresh fish water.  After 1 or 3 
days post PHZ-treatment, the fish was used for dissection and histological sectioning. 
 
Succinylacetone (SA), ALA, PBG and heme treatment of zebrafish embryos 
To potentially block endogenous heme synthesis, zebrafish embryos were dechorinated 
at 24 hpf manually and placed in embryo medium with 1mM SA (Sigma).  PTU was added to 
block pigmentation in embryos.  ALA (1 mM), PBG (250 µM) or heme (10 µM) were added 
to embryos medium for treatment. 
 
Fixation of adult zebrafish for histological section 
Adult zebrafish (5-6 months old) were anesthetized with 0.02 % tricaine in fish water.  
Adult fish was slitting along the ventral abdominal wall from anus opening, allowing the 





times of fish volume.  Adult fish was first fixed by modified davidson’s fixative (to make 1L, 
mix 220 ml Formaldehyde (37-40 %), 115 ml Glacial acetic acid, 330 ml 95 % Ethyl alcohol 
and 335 ml Distilled water) for 24-48 h.  The carcasses are then rinsed in 70 % ethanol and 
then stored in 10 % Neutral buffered formalin (NBF).  Each specimen is paraffin-embedded 




The kidneys and spleens from 5-6 months old adult zebrafish (four genotypes: 
hrg1a+/iq261; hrg1b+/iq361, hrg1aiq261/iq261; hrg1b+/+, hrg1a+/+; hrg1biq361/iq361 and hrg1aiq261/iq261; 
hrg1biq361/iq361) were dissected out and flash-frozen in TRIzol before RNA extraction (3 fish 
as a cohort, 3 cohorts per genotype).   
Total RNA was extracted following TRIzol manual (Invitrogen).  Extracted RNA was 
then digested with RNase free-DNase to remove remaining genomic DNA and cleaned up 
using Qiagen RNA mini column (Qiagen, Germany).  Quality and quantity of total RNA 
were checked by Agilent Bioanalyzer 2100 (Appendix IX).  Spleen (100 ng) or Kidney (1 
µg) of total RNA were used for RNAseq library construction.  Purified mRNA was prepared 
from total RNA following the manufactory’s manual of NEBNext® Poly-A) mRNA Magnetic 
Isolation Module (E7490S, New England Biolabs).  RNAseq libraries was constructed with 
NEBNext® Ultra™ RNA Library Prep Kit for Illumina® (E7530L, New England Biolabs).  
The RNAseq libraries and fragment size was roughly qualified by Agilent Bioanalyzer 2100 
(Appendix X, XI).  RNAseq libraries were quantified using NEBNext® Library Quant Kit for 
Illumina® (E7630S, New England Biolabs). 
RNAseq was performed using STAR-DESeq2 pipeline.  Total of 24 samples with 
single-end 50 base reads were sequenced with HiSeq 2500 (Illumina); with triplicate libraries 





using FastQC, version 0.11.5.  The reads were aligned to zebrafish GRCz10reference genome 
using STAR, version 2.5.2b.  The numbers of reads mapped to genes were counted using 
htseq, version 0.6.1p1.  Finally, differentially expressed genes were identified via DESeq2, 
version 1.12.3 with the cutoff of 0.05 on False Discovery Rate (FDR).  R version 3.3.2 (2016-
10-31) was used, and Bioconductor version 3.4 with BioInstaller version 1.24.0 were used.  
For gene annotation, we used Ensembl GRCz10, release 87.  False Discovery Rate (FDR) by 
Benjamini-Hochberg was used to determine the statistical significance with the cutoff value 
of 0.05.   
 
Yeast Methods 
Strains and Growth  
S.  cerevisiae strains W303 contained the hem1Δ mutation has been described 
previously (156, 157).  The mutant yeast cells were maintained at 30°C in yeast peptone 
dextrose (YPD) media supplemented with 250 μM ALA (Frontier Scientific).   
 
Cloning and Transformation  
To generate yeast expression plasmids, zebrafish hrg1a and hrg1b ORF were cloned 
into the pYES-DEST52 plasmid (Invitrogen).  The mutant alleles of hrg1a and hrg1b were 
amplified from cDNA of zebrafish mutants (with and without a C-terminal HA tag) and 
cloned into pYES-DEST52 plasmid.   
 
Yeast Growth Assays  
The dilution spot assays were performed as described previously (156, 157).  Plasmids 
containing potential heme transporters were transformed into hem1Δ yeast using the lithium 





(SC) (-Ura) plates supplemented with 250 μM ALA.  Several colonies with appropriate 
similar size were streaked onto 2 % w/v raffinose SC (-Ura) plates supplemented with 250 
μM ALA for 48-72 h.  The transformant yeast cells were then grown in 2 % w/v raffinose SC 
(-Ura) liquid medium without heme or ALA for at least 12 h to depleting endogenous heme.  
The concentrations of yeast were determined by OD 600 measurement.  Yeast cells were 10-
fold serially diluted with OD 600 from 0.2 to 0.00002.  The diluted yeast solutions were then 
spotted in 10 μl aliquots onto 2 % w/v raffinose SC (-Ura) plates supplemented with varying 
concentrations of heme or ALA (positive control) and 0.4 % w/v galactose to induce gene 
expression from the GAL1 promoter.  Plates only supplement with ALA and Glucose were 
treated as negative control.  Plates were incubated for 3 days before imaging.   
To assay aerobic growth exclusively, yeast were induced with 2 % galactose in the 
absence of ALA, and then spotted onto plates containing indicated heme or ALA 
concentrations as well as 2 % glycerol and 2 % lactate as carbon sources. 
 
Yeast Cell Immunoblotting 
The immunoblotting experiments were performed as previously reported (159).  
Briefly, yeasts were growing in YPD medium with 0.4 % w/v galactose to induce gene 
expression from the GAL1 promoter.  Cells were centrifuged at 5,000 x g and lysed with 
SUTEB buffer (1 % SDS, 8 M Urea, 10 mM tris-HCl, pH 7.4, 10 mM EDTA) in the presence 
of protease inhibitors (Roche).  Following cell lysis, the lysates were centrifuged at 14,000 x 
g, 5 min and the supernatant was collected in clean 1.7ml Eppendorf tubes.  Total protein 
concentrations were quantified using the BCA method (Thermo Scientific).  Equal amount of 
total protein of each sample was loaded on 12 % SDS-PAGE and transferred to 45 µM 
nitrocellulose membrane with semi-dry transfer apparatus (Bio-Rad).  The membranes were 
blocked overnight and incubated with either Hrg1 antibody or rabbit anti-HA (Sigma) as 





conjugated goat anti-rabbit antibody at a 1:30,000 dilution for 1 h at RT.  For loading control, 
the membranes were re-probed with anti-PGK1 at 1:5,000 (Invitrogen).  Signal was detected 
by using SuperSignal Chemiluminescence reagents (Thermo Scientific) in the Gel 






Chapter 3: Hrg1 is dispensable for primitive erythrocytes 
maturation in zebrafish 
Summary 
HRG1 was identified as the first bona fide eukaryotic heme importer conserved 
across metazoans.  We have previously shown that knockdown of zebrafish Hrg1 impaired 
primitive erythroid cell maturation, but not specification, resulting in severe anemia in 
addition to developmental defects such as hydrocephalus, body axis curvature, and a 
shortened yolk tube extension.  Subsequent genome annotation identifies two hrg1 paralogs 
in the zebrafish genome, hrg1a (slc48a1b) and hrg1b (slc48a1a) with 73% identical at the 
amino acid level.  We now show that both hrg1a and hrg1b are ubiquitously expressed in 
embryonic and adult zebrafish.  Yeast growth assays reveal that zebrafish Hrg1a and Hrg1b 
are capable of mediating heme transport.  However, knockdown of hrg1a by morpholinos 
targeting different region of RNA causes divergent phenotypes in zebrafish embryos, while 
knockdown of hrg1b does not have any visible anemic or morphological phenotypes.  To 
investigate the physiological role of Hrg1a and Hrg1b, we generated hrg1a and hrg1b double 
mutants using CRISPR/Cas9 gene-editing.  Immunoblotting revealed that Hrg1 proteins are 
absent in the hrg1aiq261/iq261; hrg1biq361/iq361 double mutants.  Intriguingly, hrg1aiq261/iq261; 
hrg1biq361/iq361 double mutants do not show overt defects in RBCs development and 
hemoglobinization, as observed in the hrg1a morphants.  Morpholino knockdown of hrg1a 
either in hrg1aiq261/iq261 or hrg1biq361/iq361 mutants caused anemia.  These results suggest that 
Hrg1 is not required for maturation and hemoglobinization of primitive erythroid cells in 
zebrafish and that the anemic phenotype of hrg1a morphants might be due to a dominant 






Hrg1 genes are duplicated in zebrafish genome 
The zebrafish genome is extensively duplicated owing to developmental gene 
duplication events in teleost (141).  There are two hrg1 paralogs in the zebrafish genome – 
hrg1a (slc48a1b) and hrg1b (slc48a1a), located on chromosome 6 and chromosome 23 
respectively (Fig. 3.1A).  Phylogenetic analysis shows that both Hrg1a and Hrg1b are HRG1 
orthologs (Fig. 3.1B).  Sequence alignment shows that the protein sequences of Hrg1a and 
Hrg1b are 73 % identity and 84 % similar (Fig. 3.1C).  TMHMM prediction suggests that 
Hrg1a and Hrg1b proteins have similar transmembrane topology as C. elegans HRG-1 
(CeHRG-1), mouse HRG1 (mHRG1) and human HRG1 (hHRG1), comprising four 
transmembrane domains, cytoplasmic N- and C-terminus (Fig. 3.1C).  Zebrafish Hrg1a and 
Hrg1b also contain highly conserved histidine residue which can potentially bind heme, as 
site-directed mutagenesis of this residue in C.elegans and human HRG1 causes loss of heme 
transport activity when expressed in yeast (Fig. 3.1C, asterisk) (159).  In summary, the 







Figure 3.1  Hrg1 is duplicated in the zebrafish genome 
A).  Loci of two hrg1 paralogs in the zebrafish genome.  Hrg1a (slc48a1b) is located on 
chromosome 6 and hrg1b (slc48a1a) is on chromosome 23.   
B).  Phylogenetic analysis of zebrafish hrg1a and hrg1b with CeHRG-1, CeHRG-4, mHRG1, 
and hHRG1.  Sequences were aligned using ClustalW2 and a phylogenetic tree was generated 
using the Neighbor-Joining method in MEGA5.   
C).  Multiple sequence alignment of zebrafish Hrg1a and Hrg1b with CeHRG-1, CeHRG-4, 
mHRG1, and hHRG1.  Asterisk, conserved histidine; black box, putative transmembrane 





Expression of hrg1a and hrg1b in embryonic stage and adult tissues 
We have previously shown that hrg1 mRNA is expressed throughout the embryo, 
including the central nervous system at the 15-somite stage and 24 hpf with WISH (69).  
However, at that time, the zebrafish genome was not fully annotated and hrg1b had not been 
identified.  Since the ORFs of hrg1a and hrg1b are 84 % sequence similar, we were unable to 
differentiate the temporospatial expression of hrg1a and hrg1b by using full-length ORF as 
RNA probes for WISH.  To determine the temporospatial expression of hrg1a and hrg1b 
mRNA, we exploited sequence difference in the 3’UTR region of hrg1a and hrg1b mRNA to 
synthesize the probes for WISH.  Expressions of hrg1a and hrg1b mRNA are very similar 
with ubiquitous expression throughout the developing embryo and strong expression in the 
central nervous system (Fig. 3.2A and B).  Both hrg1a and hrg1b mRNA can be detected by 
WISH at one-cell stage, suggesting that the hrg1a and hrg1b mRNA detected before 3 hpf are 
maternally deposited during oogenesis, as zygotic mRNA expression is occurred after 3 hpf 
in the zebrafish embryo (160).   
Total mRNA was extracted from embryos at different stages, from one-cell to 4 dpf 
(day post fertilization).  RT-PCR analysis shows that the temporal expression patterns of 
hrg1a and hrg1b are similar and both hrg1a and hrg1b mRNA are maternally deposited in the 
developing embryos (Fig. 3.2C).  Quantitative RT-PCR (qRT-PCR) shows embryonic 
expression of hrg1a is relatively greater than hrg1b (Fig. 3.2D), with maternal hrg1a and 
hrg1b mRNA being highly expressed during early embryonic stages compared to zygotic 







Figure 3.2  Hrg1a and hrg1b mRNA expression in zebrafish embryos 
A) and B).  WISH of hrg1a and hrg1b expression in embryos at different developmental 
stages.  Anterior is to the left.  Anti-sense probe is used to detect mRNA expression; sense 
probe is shown to indicate background staining.  Scale bar: 200 µm. 
C).  RT-PCR of hrg1a and hrg1b mRNA in zebrafish embryos at different developmental 
stages.  ß-actin is the control for house-keeping gene; cbfb is a transcription factor which is 
expressed around 18 hpf. 
D).  qRT-PCR of hrg1a and hrg1b mRNA in zebrafish embryos at different developmental 
stages.  Fifty embryos before 24 hpf were pooled as one cohort.  Thirty embryos at stages on 
or later than 24 hpf were pooled as one cohort.  Three cohorts of pooled embryos at each 





To determine the expression of hrg1a and hrg1b in adult zebrafish, both female and 
male zebrafish were dissected and tissues were collected for total RNA extraction.  qRT-PCR 
was preformed to determine expression of hrg1a and hrg1b in various adult zebrafish tissues.  
hrg1a and hrg1b are widely expressed in adult zebrafish, however, with different expression 
intensity (Fig. 3.3A and B).  Both hrg1a and hrg1b are highly expressed in the brain, which 
is consistent with the WISH results.  Surprisingly, expression level of hrg1b mRNA is higher 
than hrg1a in peripheral blood in both male and female.  hrg1a and hrg1b is also expressed in 
the kidney, the major hematopoietic tissue in adult zebrafish, suggesting a potential role of 
Hrg1a and Hrg1b in adult erythropoiesis.  Additionally, both hrg1a and hrg1b are expressed 
in spleen, an organ which clears senescent or damaged RBCs and recycles heme-iron.  
Consistent with the high expression levels of hrg1a mRNA in embryos at one-cell stage, 
hrg1a mRNA is abundant in the ovary.   
Confocal microscopy studies in HEK293 cells expressing fluorescently tagged proteins 
show that Hrg1a and Hrg1b are distributed in intracellular compartments, co-localizing with 
LAMP1, a lysosomal marker, consistent with previous studies for worm and human HRG1 
(Fig. 3.4) (69).  Co-expression of fluorescent protein tagged Hrg1a and Hrg1b resulted in 
both proteins co-localizing to the same intracellular vesicles.  These results suggest that 
zebrafish Hrg1a and Hrg1b are located primarily in the endosomes and lysosomes-related 








Figure 3.3  Expression of hrg1a and hrg1b mRNA in adult zebrafish tissues 
A).  qRT-PCR of hrg1a and hrg1b mRNA in dissected tissues from adult male. 
B).  qRT-PCR of hrg1a and hrg1b mRNA in dissected tissues from adult female  
Two male or female fish were dissected as one cohort, and each gender had three cohorts as 








Figure 3.4  Subcellular localization of fluorescent tagged Hrg1a and Hrg1b when 
expressing in HEK293 cells 
Confocal microscopy of subcellular localization of Hrg1a and Hrg1b with C-terminus tagged 
fluorescent proteins in transfected HEK-293 cells.  LAMP1 is a marker for lysosomal 






Expression of Hrg1 in a heterologous system improves utilization of exogenous 
heme 
To determine whether zebrafish Hrg1 is able to transport heme, we utilized previously 
established growth assays in yeast.  The heme biosynthetic pathway is conserved among 
eukaryotes, with the first step catalyzed by ALAS.  In yeast, mutation in hem1 (hem1Δ), 
which encodes ALAS, causes failure in production of δ-aminolevulinic acid (ALA), an 
intermediate of heme synthesis.  The growth of hem1Δ mutants can be rescued by 
supplementation with ALA or by providing excess of exogenous heme in the growth medium 
(156, 157).  Expression of a heme importer can greatly ameliorate growth defects of hem1Δ 
in low concentrations of exogenous heme (159).   
We previously showed that the expression of CeHRG-1 or CeHRG-4 greatly improves 
hem1Δ yeast growth in the presence of low heme concentration (69).  Expression of zebrafish 
Hrg1a and Hrg1b also showed the same rescued growth of hem1Δ yeast in the presence of 
exogenous heme (0.25 µM and 10 µM), suggesting that Hrg1a and Hrg1b can mediate heme 






Figure 3.5  Hrg1a and Hrg1b are capable of heme transport upon expression in 
yeast 
A).  Yeast growth assay showing zebrafish Hrg1a and Hrg1b are able to mediate heme 
transport in yeast.  The hem1Δ strains transformed with empty vector pYes-DEST52, 
CeHRG-4, CeHRG-1, Hrg1a and Hrg1b were cultivated overnight and spotted in serial 







Transient knockdown of hrg1a or hrg1b by morpholinos in zebrafish embryos 
The yeast growth assays showed that Hrg1a and Hrg1b are both capable of rescuing the 
growth of hem1Δ yeast, suggesting that zebrafish Hrg1a and Hrg1b are functionally 
interchangeable heme transporters.  To elucidate Hrg1a and Hrg1b function in zebrafish 
embryonic development and erythropoiesis, gene knockdowns by antisense morpholino were 
utilized to transiently block the expression of hrg1a and hrg1b in zebrafish embryos.  Both 
translation-blocking and pre-mRNA splice-blocking morpholinos were designed to 
knockdown the gene expression of hrg1a and hrg1b (Fig. 3.6A).  The translation-blocking 
morpholino is designed to target the ATG start codon and can inhibit protein translation 
initiation by preventing ribosome binding to the mature mRNA.  The pre-mRNA splice-
blocking morpholino is designed to target the exon-intron boundaries and can selectively 
induce mRNA mis-splicing with either retained introns or deleted exons.  The morpholinos 
were delivered by microinjection into zebrafish embryos at the one-cell stage.  
Hemoglobinization was determined by o-dianisidine staining of RBCs (99).  hrg1a 
knockdown by pre-mRNA splice-blocking morpholino, which targeted the boundary of hrg1a 
intron 2 and exon 3 (Hrg1a_I2E3_MO2), caused body curvature defects and severe anemia, 
consistent with previously published results (Fig. 3.6B) (69).  However, hrg1a translation-
blocking morpholino (Hrg1a_ATG_MO) and another splicing-blocking morpholino targeting 
hrg1a exon 2 and intron 2 (Hrg1a_E2I2_MO1) boundaries did not cause comparable 
phenotypes as Hrg1a_I2E3_MO2.  In contrast, knockdown of hrg1b by either translation-
blocking (Hrg1b_ATG_MO) or splice-blocking morpholino (Hrg1b_E2I2_MO) did not cause 
anemic phenotype (Fig. 3.6B).   
To evaluate the efficiency of hrg1a or hrg1b knockdown by splice-blocking 
morpholino, RT-PCR analysis was performed on total mRNA extracted from these 
morphants.  hrg1a mRNA expression was efficiently blocked by Hrg1a_E2I2_MO1 resulting 





(Appendix II).  Hrg1b expression was also efficiently disrupted by Hrg1b_E2I2_MO 
knockdown causing a deletion of hrg1b exon 2 and mRNA degradation, probably through 
nonsense mediated decay (Appendix IV).  Knockdown of either hrg1a or hrg1b by splice-
blocking morpholinos did not affect the expression of the other paralog (Fig. 3.7A).  
Although causing severe anemia, knockdown of hrg1a by Hrg1a_I2E3_MO2 showed 
partially defective splicing of hrg1a mRNA (Appendix III), with majority of hrg1a mRNA 
intact (Fig. 3.7A). 
The efficiency of translation-blocking morpholinos was determined by immunoblotting 
with Hrg1 antibody.  As Hrg1a_ATG_MO and Hrg1b_ATG_MO decreased Hrg1 protein 
individually, co-injection of Hrg1a_ATG_MO and Hrg1b_ATG_MO together greatly reduced 







Figure 3.6  Knockdown of hrg1a and hrg1b by multiple morpholinos 
A).  Targeting sites of morpholinos for hrg1a and hrg1b.  Two splice-blocking and one 
translation-blocking morpholinos for hrg1a, one splice-blocking and one translation-blocking 
morpholino for hrg1b were designed.  The control morpholino (Ctrl_MO) was injected as a 
random scramble control in these knockdown experiments.  Each morpholino is 25 nt in 
length.   
B).  O-dianisidine staining of 3 dpf embryos after injection of indicated morpholinos at the 
one-cell stage.  Knockdown of zebrafish hrg1a by Hrg1a_I2E3_MO2 results in body 
curvature and severe anemia, as indicated by reduced o-dianisidine-positive RBCs.   






Figure 3.7  Knockdown efficiency by morpholinos 
A).  Knockdown efficiency of Hrg1a_E2I2_MO1, Hrg1a_I2E3_MO2, Hrg1b_E2I2_MO by 
RT-PCR.  Hrg1a_E2I2_MO1 blocks original splicing acceptor site and utilizes 25 nt 
downstream splicing acceptor, causing 25 nt longer ORF with frameshift (red arrow).  
Hrg1a_I2E3_MO2 partially blocks the splicing on intron 2 and exon 3 junction, resulting in 
small-sized cDNA with deletion of exon 3 (red arrow), however, majority of hrg1a mRNA is 
normal.  Hrg1b_E2I2_MO causes deletion of exon 2, resulting in small sized hrg1b cDNA 
(red arrow).  Knockdown hrg1a or hrg1b did not affect cDNA of the other paralog.  Red 
arrows show the PCR products of cDNA affected by morpholino knockdown.   
B).  Co-injection of Hrg1a_ATG_MO and Hrg1b_ATG_MO did not cause severe anemic 
phenotypes as shown by o-dianisidine staining at 3 dpf embryos.   
C).  Hrg1 Western blot showed Hrg1 protein was decreased by co-injection of 
Hrg1a_ATG_MO and Hrg1b_ATG_MO.  100 µg membrane fraction lysates were used for 






Generating hrg1a and hrg1b mutants by TALEN and CRISPR/Cas9 gene editing 
Antisense morpholinos are useful for transient gene knockdown due to convenience 
and high efficiency of delivery throughout the zebrafish embryos.  However, several caveats 
still exist for morpholinos, including the transient nature of knockdown, dose optimization, 
toxicity, off-target effects, and loss of knockdown efficacy in embryos that are past 50 hpf.  
To better delineate the function of Hrg1 in zebrafish, we utilized TALEN (transcription-
activator like effector nuclease) and CRISPR/Cas9 (clustered regularly interspaced short 
palindromic repeats) gene-editing to generate hrg1a and hrg1b zebrafish mutants (119, 161). 
TALEN and CRISPR-Cas9 gene editing has been shown to be capable of generating 
double strand breaks (DSB) in targeted sites with high efficiency in zebrafish (119, 161).  
DSBs are repaired by inaccurate non-homologous end joining (NHEJ), causing either an 
insertion or deletion (indel) at the targeting sites.  We used both TALEN and CRISPR for 
gene editing in our studies.  Two pairs of TALEN for hrg1a, and two CRISPRs for hrg1a and 
hrg1b were used in this study.  All these sites were chosen from in silico optimization to 
minimize off-target effects for each TALEN pair and CRISPR.   
To check the efficiency of each TALEN for hrg1a, TALEN mRNA was obtained by 
in-vitro transcription and two mRNAs for one TALEN pair were co-injected in equimolar 
concentration into zebrafish embryos at the one-cell stage.  The efficiency and specificity of 
TALEN induced indels on target site was determined by single embryo PCR.  Genotyping on 
injected embryos was performed next day after microinjection to determine the efficiency of 
TALEN and whether the embryos contained mutation in the expected target site.  The indels 
in the target sites resulted in loss of restriction sites within the two TALEN recognition sites, 
AvaII for hrg1a exon2 and Sau96I for hrg1a exon 3 (Fig. 3.8A and B).  DNA fragments 
were amplified using primers on both sides of TALEN targeting sites.  Embryos injected with 
mRNA encoding TALENs revealed undigested PCR products when treated with AvaII or 





Sequencing results on the purified undigested PCR products confirmed that indels were 
induced at the target sites (Fig. 3.8A and B).  These results demonstrated that TALENs 
induce DSBs and random indels occur due to NHEJ. 
To generate null mutants for hrg1a with large-size deletion, two pairs of verified hrg1a 
TALENs were co-injected into zebrafish embryos at one-cell stage.  If both TALEN pairs 
successfully make DSBs on exon 2 and exon 3 at the same allele, it may take out a large 
fragment of DNA sequence between two TALEN targeting sites and lead to a larger deletion 
of up to ~2.5 kb in the hrg1a gene locus between exon 2 and exon 3 (Fig. 3.9A).  The 
deletion of ~2.5 kb can be detected using primers flanking these two TALEN cutting sites, 
resulting in a smaller size PCR product after deletion.  Seven out of twenty-five F0 chimeric 
founders were identified to carry large-size deletion at hrg1a locus, with various lengths of 
deletions (Fig. 3.9B).  Subsequent sequencing results confirmed the large-sized deletion at 
hrg1a locus (Fig. 3.9C).  One founder (No.5) carried an entire deletion of ~2.5 kb sequence 
between two TALEN targeting sites, whereas No. 1, No. 2, No. 7 founders had insertions of 
different DNA sequences after the ~2.5kb deletion.   
TALEN is efficient in gene-editing and generating mutants in zebrafish, however, the 
assembly of each TALEN pair is tedious and time-consuming.  While my project was coming 
along, CRISPR/Cas9 technology was established and demonstrated to have a much higher 
efficiency in term of inducing DSB in DNA sequence, together with easier assembly (120).  
A functional unit of CRISPR/Cas9 contains two elements, gRNA and Cas9 nuclease.  The 
gRNA can be specifically designed to target 20 nt sequence and recruit Cas9 nuclease to its 
target sequence to induce DSBs.  Co-injection of multiple gRNAs together with Cas9 mRNA 
was used to generate multiple mutations or large-size deletions in zebrafish embryos (162).  
To generate large-sized deletion mutants for hrg1a and hrg1b, two different gRNAs targeting 
exon 2 and exon 4 in hrg1a locus, and two different gRNAs targeting exon 1 and exon 3 in 





3.11A).  Twenty-four F0 chimeric founders were raised to adult for genotyping; four among 
these carried deletions in hrg1a and two for hrg1b (Fig. 3.10B and Fig. 3.11B).  Sequencing 
results confirmed the disruption of hrg1a and hrg1b loci in these F0 founders (Fig. 3.10C, 
Fig. 3.11C). 
F0 chimeric founders with large-sized deletion of hrg1a or hrg1b were further crossed 
to WT to generate F1 offsprings.  If the large-size deletion is heritable via the germline, we 
can generate stable F1 heterozygote of hrg1a or hrg1b mutants.  However, we were unable to 
obtain hrg1a or hrg1b mutants with the large deletion even after screening over 300 F1 fish 
(Table 3.1).  This was unexpected since we obtained high efficiency gene-editing by TALEN 
or CRISPR in our pilot screening of individual injected embryos and chimeric F0 founders.  
It is possible that large-size deletion may cause genome instability which will result in 
embryonic lethality. 
Instead of screening for large-size deletion, we decided to screen for smaller indels 
(Fig. 3.12).  Several hrg1a mutant alleles carrying different indels were retrieved from 
TALEN gene-editing.  hrg1aiq210 has a deletion of 10 nt in exon 2, while hrg1aiq305 carries a 5 
nt deletion in exon 3, resulting in a frameshift of hrg1a ORF (Fig 3.12A).  We also obtained 
hrg1 mutants with two indels in the same allele.  hrg1aiq1001 mutant allele carries two indels in 
hrg1a locus: 10 nt deletion in exon 2, and 1nt deletion in exon 3 (Fig. 3.12A).  We also 
selectively retrieved several mutants for hrg1a and hrg1b by CRISPR/Cas9.  hrg1aiq261 
carries a 61 nt deletion and 7nt insertion resulting in deletion of the ATG translation start site 
(Fig. 3.12B).  Computational analysis reveals that hrg1biq306 has a 6 nt substitution in exon 3, 
causing a pre-mature stop codon with a deletion of 17 aa in the C-terminus of the mature 
protein, while Hrg1biq361 has a 61nt deletion which causes a truncation and removal of 28 aa 







Figure 3.8  Targeted disruption of hrg1a in zebrafish by TALENs 
A).  TALEN targeting site on hrg1a exon 2.   
B).  TALEN targeting site on hrg1a exon 3.   
The binding sites of TALEN pair are shown as red bold uppercase.  The space region is 
shown as lowercase with restriction site (red text).  Detection of mutations in injected 
embryos was performed by AvaII (exon 2) or Sau96I (exon 3) digestion.  PCR product with 
potential indels at the AvaII or Sau96I site cannot be cut (uncut band).  Complete digestion of 
PCR products with AvaII or Sau96I can be detected using genomic DNA as a control.  






Figure 3.9  Targeted deletion of large-size fragment between exon 2 and exon 3 
in hrg1a by using two TALEN pairs 
A).  Structure and sequence of hrg1a TALEN targeting sites, showing the binding sites (red 
bold uppercase) of TALENs.  The space region is shown as lowercase with restriction site (red).   
B).  Detection of large-sized deletion in F0 founders by PCR and DNA gel electrophoresis.  If 
both TALENs cut, the PCR product will be smaller than that amplified from genomic DNA 
(gDNA).   







Figure 3.10  Targeted deletion of hrg1a by CRISPR /Cas9. 
A).  Target sites in Hrg1a for CRISPR.  The vertical arrows show the location of Cas9 cutting 
sites.  The horizontal arrows indicate the primers for PCR. 
B).  Detection of deletion in injected embryos by PCR and DNA gel electrophoresis.   
C).  Sequencing results of PCR products from embryos with positive targeted deletion caused 






Figure 3.11  Targeted deletion of hrg1b by CRISPR /Cas9. 
A).  Target sites in Hrg1a for CRISPR.  The vertical arrows showed the location of Cas9 cutting 
sites.  The horizontal arrows indicate the primers for PCR 
B).  Detection of deletion in injected embryos by PCR and DNA gel electrophoresis.   








Table 3.1  Screening of hrg1a and hrg1b mutants with large-size deletion 
Seven out of twenty-five F0 founders generated by TALENs were shown to carry 
large-size deletion in hrg1a locus.  Four out of twenty-four F0 founders generated by 
CRISPR/Cas9 were shown to carry large-size deletion in hrg1a locus.  For hrg1b, 
two F0 founders generated by CRISPR/Cas9 were shown to carry large-size deletion.  
The positive F0 founders were further crossed with WT to generate F1 progenies.  
Indicated numbers of F1 offsprings were screened, however no heritable germline 











Figure 3.12  Hrg1a and hrg1b mutant alleles generated by TALEN or 
CRISPR/Cas9 gene-editing. 
A).  Hrg1a mutant alleles generated by TALEN.   
B).  Hrg1a mutant allele generated by CRISPR. 
C).  Hrg1b mutant alleles generated by CRISPR.   
The underline texts show the TALEN or CRISPR targeting sequences.  The deleted 







Mutant forms of Hrg1a and Hrg1b cannot rescue the growth of heme-deficient 
yeast 
To evaluate whether mutant forms of Hrg1a and Hrg1b created by TALEN and 
CRISPR/Cas9 are functional, we determined whether the putative proteins encoded by these 
mutants can rescue the growth of hem1Δ yeast.  For hrg1aiq210 and hrg1aiq261 mutant alleles, 
the putative ORF with the downstream potential alternate translation start site was cloned, 
with the truncation of 34 aa in the N-terminus.  Compared to wild type Hrg1a and Hrg1b, 
none of the mutant constructs rescued hem1Δ growth in the presence of exogenous heme 
(Fig. 3.13A).  RT-PCR on total RNA extracted from transformed yeast revealed that the WT 
and mutant forms of hrg1a and hrg1b were transcribed in the transformed yeast (Fig. 3.13B).  
Immunoblotting showed that some mutant forms of Hrg1a and Hrg1b protein were expressed 
in yeast transformants (Fig. 3.13C and D).  Collectively, these results suggest that the mutant 








Figure 3.13  Mutant forms of Hrg1a and Hrg1b cannot rescue hem1Δ growth in 
the presence of exogenous heme 
A).  Yeast growth assay with mutant forms of Hrg1a and Hrg1b.  The hem1Δ strain 
transformed with empty vector pYes-DEST52, Hrg1a, Hrg1b, mutant forms of Hrg1a and 
Hrg1b were cultivated overnight and spotted in serial dilutions on SC plates supplemented 
with 250 µM ALA and indicated concentration of heme. 
B).  RT-PCR showing both WT and mutant forms of hrg1a and hrg1b ORFs are transcribed 
in transformed yeast. 
C).  Mutant forms of Hrg1a are expressing in yeast revealed by immunoblotting.  Hrg1a 
truncated ORF is generated by using downstream alternative ATG translation start site, with 
deletion of 38aa at N-terminus.  The other hrg1a mutant alleles hrg1aiq1001 and hrg1aiq305 
caused frameshift, expressed proteins cannot be recognized by Hrg1 antibody.   
D).  Western blot showing mutant forms of HA-tagged Hrg1b are expressing in yeast.  
Hrg1biq361 and hrg1biq306 mutant alleles caused frameshift, thus c-terminus HA-tag version 
was used for yeast growth assay. Imuunoblotting on HA showed both Hrg1biq361 and 





Hrg1 knockout zebrafish are viable despite no detectable Hrg1 proteins  
We next crossed hrg1aiq261 and hrg1biq361 zebrafish mutants to obtain double 
heterozygous, which were then intercrossed to generate hrg1aiq261/iq261; hrg1biq361/iq361 double 
mutants.  Genotyping of hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 
revealed that hrg1 mutants can survive to 3 dpf (Fig. 3.14A).  Immunoblotting with Hrg1 
antibody on genotyped 3 dpf embryos confirmed no detectable Hrg1 protein in hrg1aiq261/iq261; 
hrg1biq361/iq361 double mutants (Fig. 3.14B).  Intercrossing of hrg1a+/iq261; hrg1b+/iq361 
produced expected Mendelian segregation of hrg1aiq261/iq261; hrg1biq361/iq361 double mutants 
(Table 3.2) (Chi-square test, p > 0.05).  hrg1aiq261/iq261; hrg1biq361/iq361 can survive to 







Figure 3.14  Genotyping and immunoblotting of hrg1aiq261/iq261; hrg1b iq361/iq361, 
and hrg1aiq261/iq261; hrg1biq361/iq361. 
A).  Genotyping of hrg1aiq261/iq261; hrg1b iq361/iq361, and hrg1aiq261/iq261; hrg1biq361/iq361 3 dpf 
zebrafish embryos.  Hrg1aiq261/iq261 has an indel of -61 nt, and +7 nt in exon 2; and hrg1b 
iq361/iq361 carries -61nt deletion in exon 3, causing small-sized PCR products. 
B).  Immunoblotting on Hrg1 of membrane fraction lysates from wild-type WT, 
hrg1aiq261/iq261, hrg1biq361/iq361 and double mutant hrg1aiq261/iq261; hrg1biq361/iq361.  Each crude 
membrane fraction lysate was from pooled ~30 embryos.  Each lane represented 100 µg 






Table 3.2  Intercross of hrg1a+/iq261; hrg1b+/iq361 shows progenies with expected 
mendelian ratio 
Screening of progenies from intercross of hrg1a+/iq261; hrg1b+/iq361 at the stage of 3 dpf with 








Hrg1aiq261/iq261; hrg1biq361/iq361 double mutants do not show defects in embryonic 
erythropoietic differentiation and RBC hemoglobinization 
To characterize whether hrg1aiq261/iq261, hrg1biq361/iq361 or hrg1aiq261/iq261; hrg1biq361/iq361 
double mutant embryos have overt defects in primitive erythropoiesis, WT and mutant 
embryos were collected for WISH.  No alteration for gata1, a transcription factor required for 
primitive erythropoiesis lineage, and ae1, a marker for developing RBCs in intermediate cell 
mass was observed at 1 dpf.  These results indicate that there are no defects in erythropoietic 
differentiation in hrg1aiq261/iq261, hrg1biq361/iq361 or hrg1aiq261/iq261; hrg1biq361/iq361 mutant 
embryos (Fig. 3.15) (n = 30).  To characterize whether hrg1aiq261/iq261, hrg1biq361/iq361 or 
hrg1aiq261/iq261; hrg1biq361/iq361 double mutant embryos have deficiency in RBC maturation and 
hemoglobinization, we performed o-dianisidine staining for embryos at 3 dpf.  We did not 
detect defects in RBC hemoglobinization in any of these three mutants at 3 dpf compared to 
WT (n = 50) (Fig. 3.16A).  We next examined whether there are any hematological 
phenotypes at the cellular level by withdrawing circulating peripheral blood from 3 dpf 
zebrafish embryos; O-dianisidine staining of isolated primitive RBCs showed no obvious 
differences in hemoglobinization with the RBCs in the peripheral blood of hrg1aiq261/iq261, 
hrg1biq361/iq361 or hrg1aiq261/iq261; hrg1biq361/iq361 (Fig. 3.16B).  We also crossed the 
hrg1aiq261/iq261, hrg1biq361/iq361 or hrg1aiq261/iq261; hrg1biq361/iq361 mutants into the globinLCR: 
GFP transgenic zebrafish.  FACS quantification further confirmed that there were no 
differences in GFP+ cells between WT and mutant zebrafish embryos (Fig. 3.17) (Two way 
ANOVA, p>0.05).  In addition, May-Grünwald-Giemsa staining on isolated primitive 
erythrocytes showed no alternations in RBC morphology from 3 dpf embryos (Fig. 3.18).  
Collectively, these results suggest that no measurable defects were detected in the 
erythropoietic lineage for hrg1aiq261/iq261, hrg1biq361/iq361 or hrg1aiq261/iq261; hrg1biq361/iq361 





differences in iron or heme content in hrg1aiq261/iq261, hrg1biq361/iq361 or hrg1aiq261/iq261; 






Figure 3.15  Expression of ae1 and gata1 in hrg1aiq261/iq261, hrg1biq361/iq361 and 
hrg1aiq261/iq261; hrg1biq361/iq361 mutants  
Lateral view of ae1 and gata1 expression by WISH at 1 dpf embryos from WT, 
hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361.  Anterior is to the left.  N=50 







Figure 3.16  No defects in RBC hemoglobinization in hrg1aiq261/iq261, 
hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 mutants 
A).  O-dianisidine staining of RBCs in 3 dpf embryos from WT, hrg1aiq261/iq261, hrg1biq361/iq361 
and hrg1aiq261/iq261; hrg1biq361/iq361 (n=50 for each genotype).  Scale bar: 200 µm. 
B).  O-dianisidine staining of isolated RBCs from peripheral blood of 3 dpf embryos.  






Figure 3.17  Quantification of GFP+ cells of hrg1aiq261/iq261, hrg1biq361/iq361 and 
hrg1aiq261/iq261; hrg1biq361/iq361 in globinLCR: GFP transgenic background  
A).  Representative FACS analysis to show percentages of GFP+ cells in globinLCR: GFP 
embryos. 
B).  Quantitative percentages of GFP+ cells in WT, hrg1aiq261/iq261, hrg1biq361/iq361 and 
hrg1aiq261/iq261; hrg1biq361/iq361 mutants in globinLCR: GFP transgenic background.  
GlobinLCR: GFP; hrg1a+/iq261; hrg1b+/iq361 were crossed with hrg1aiq261/iq261; hrg1biq361/iq361 to 
produce progenies with hrg1a+/iq261; hrg1b+/iq361, hrg1aiq261/iq261; hrg1b+/iq361, 
hrg1a+/iq261hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 in globinLCR: GFP transgenic 
background.  Progenies were genotyped at 3 dpf by tail-clip.  Thirty embryos of each 
genotype were pooled and disaggregated to single cell suspension for FACS analysis.  Error 








Figure 3.18  Morphology of RBCs from 3 dpf embryos of hrg1aiq261/iq261, 
hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 
A).  May-Grünwald-Giemsa staining of isolated peripheral RBCs at 3 dpf embryos from WT, 
hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361.  Circulated RBCs were 







Figure 3.19  ICP-MS of 3 dpf embryos from WT, hrg1aiq261/iq261, hrg1biq361/iq361 
and hrg1aiq261/iq261; hrg1biq361/iq361 
Around sixty embryos were pooled and flash-frozen for ICP-MS analysis.  Error bars indicate 






Knockdown of hrg1b in hrg1a mutant embryos or vice versa depletes Hrg1 
protein but lacks anemic phenotypes  
One explanation for the discrepancy between morpholino knockdown and gene 
knockout is that morpholinos have an acute effect, while effects in gene knockout mutants are 
chronic and long-lasting permitting genetic compensation to occur.  We therefore knocked 
down hrg1b in the hrg1a mutant background and vice versa.  Hrg1aiq210/iq210 has a 10nt 
deletion in exon 2 after ATG translation start codon causing a +1 frameshift in the ORF.  
Although hrg1aiq210 may utilize an alternative downstream ATG in silico, the predicted 
truncated protein with loss of 34aa in N-terminus is not functional based our yeast growth 
assay (Fig. 3.13).  Knockdown of hrg1b by translation-blocking Hrg1b_ATG_MO or splice-
blocking Hrg1b_E2I2_MO in hrg1aiq210/iq210 did not show any significant anemic phenotype 
(Fig. 3.20A).  RT-PCR revealed that hrg1b mRNA was decreased by Hrg1b_E2I2_MO in 
both WT and hrg1aiq210/iq210 mutants(Fig. 3.20B).  Since hrg1a and hrg1b gene sequences 
have relatively high similarity, we also checked whether knockdown of hrg1b altered the 
expression of hrg1a.  Knockdown of hrg1b by Hrg1b_E2I2_MO did not affect hrg1a mRNA 
expression (Fig. 3.20B).  In hrg1aiq210/iq210 embryos, knockdown of hrg1b by either 
Hrg1b_ATG_MO or Hrg1b_E2I2_MO showed little or no detectable Hrg1 proteins (Fig. 
3.20A, 3.20C).  These results show that knockdown of hrg1b in the hrg1a mutants does not 







Figure 3.20  Knockdown of hrg1b in hrg1aiq210/iq210 causes loss of Hrg1 protein 
without anemic phenotypes 
A).  O-dianisidiane staining of embryos injected with indicated morpholinos. 
B).  RT-PCR on morphants from control_MO and Hrg1b_E2I2_MO.  Hrg1aiq210 mutant allele 
has a 10 nt deletion causing loss of AvaII restriction sites.  PCR product from hrg1aiq21/iq210 0 
has a slightly smaller size and cannot be digested by AvaII.  Hrg1b mRNA is tremendously 
decreased by Hrg1b_E2I2_MO morpholino knockdown.   
C).  Immunoblotting of Hrg1 proteins in membrane fraction of embryos injected with 





It is important to note that the hrg1a morpholino binding site is still intact in the 
TALEN induced hrg1aiq210 mutant.  We therefore injected Hrg1a_I2E3_MO2 into 
hrg1aiq210/iq210 mutant embryos to check whether the phenotypes brought by 
Hrg1a_I2E3_MO2 injection still persists.  Knockdown of hrg1a by Hrg1a_I2E3_MO2 
resulted in profound anemia together with morphological defects, even though hrg1aiq210/iq210 
mutants do not show detectable Hrg1a protein (Fig. 3.21A).  RT-PCR revealed that a small 
percentage of hrg1a mRNA expression was mis-spliced in the Hrg1a_I2E3_MO2 injected 
morphants (Fig. 3.21B).   
We next knocked down hrg1a by injecting Hrg1a_ATG_MO, Hrg1a_E2I2_MO1, or 
Hrg1a_I2E3_MO2 morpholinos into either WT or hrg1biq361/iq361 mutant background.  
Injection of Hrg1a_ATG_MO and Hrg1a_E2I2_MO1 to either WT or hrg1biq361/iq361 mutant 
did not result in severe anemia, but injection of Hrg1a_I2E3_MO2 morpholino knockdown 
again caused developmental defects with anemic phenotypes (Fig. 3.22A and B). If hrg1a 
morpholinos can efficiently decrease hrg1a expression, we should not detect Hrg1 protein in 
the hrg1biq361/iq361 mutant background.  Injection of all these morpholino significantly reduced 
Hrg1 protein levels in the hrg1biq361/iq361 mutant.  These results suggest that 






Figure 3.21  Morpholino knockdown of hrg1a by Hrg1a_I2E3_MO2 in 
hrg1aiq210/iq210 still causes profound anemia 
A).  Injection of Hrg1a_I2E3_MO2 causes anemic phenotypes in both WT and Hrg1aiq210/iq210 
mutant embryos.   
B).  RT-PCR of hrg1a and hrg1b in Hrg1a_I2E3_MO2 morphants.  Hrg1a is only partially 
affected by Hrg1a_I2E3_MO2 in both WT and Hrg1aiq210/iq210 mutants, as the mis-spliced 
mRNA shown by red arrows.  AvaII digestion is shown as RFLP genotyping of WT and 
Hrg1aiq210 mutant embryos and PCR product from Hrg1aiq210 cannot be digested by AvaII.  






Figure 3.22  Knockdown hrg1a by Hrg1a_I2E3_MO2 results in anemia without 
depleting Hrg1 protein 
A).  O-dianisidine staining of 3 dpf embryos after injection indicated morpholinos at one-cell 
stage in WT and hrg1biq361/iq361 mutant.  Scale bar: 200 µm.   
B).  Quantification of anemic embryos shown as a percentage of overall injected embryos. 
C).  Immunoblotting of Hrg1 protein from membrane fractionation lysates of 3 dpf morphants 
with injection of indicated morpholinos.  Each lane represented 100 µg protein lysates.  






P53 inhibition does not ameliorate Hrg1a_I2E3_MO2 morphants 
One possible explanation for the discrepancies in phenotypes between morpholinos and 
deletion mutants is p53 upregulation due to morpholino injections (163).  Consequently, 
knockdown of p53 by morpholino alleviates off target effects without affecting phenotypes 
associated with gene-specific morpholino knockdown.  To test whether the phenotypes of 
Hrg1a_I2E3_MO2 morphants are ascribed to p53 activation, we co-injected 
Hrg1a_I2E3_MO2 and p53_MO into one-cell stage zebrafish embryos and evaluated the 
hemoglobinization of 3 dpf embryos.  Injection of p53_MO did not ameliorate the anemic 






Figure 3.23  Co-injection of Hrg1a_I2E3_MO2 and p53_MO does not ameliorate 
the phenotypes in Hrg1a_I2E3_MO2 morphants 
A).  O-dianisidine staining of 3 dpf embryos after injection of indicated morpholinos at one-
cell stage in t WT and hrg1aiq261/iq261 mutant.  Scale bar: 200 µm.   






Inhibiting heme synthesis in zebrafish embryos results in anemia but cannot be 
rescued by heme supplementation 
Zebrafish, like most metazoans, synthesis the heme through a highly conserved eight-
step biosynthetic pathway.  The majority of heme in zebrafish embryos comes from 
endogenous heme synthesis.  Thus, zebrafish embryos may not require a heme importer such 
as Hrg1 to maintain heme levels.  However, given that single-cell embryos contain hrg1a and 
hrg1b mRNA and that hrg1a is highly expressed in the ovaries, we decided to establish a 
condition for heme synthesis deficiency in the embryos to tease out a potential role for Hrg1 
in the absence of heme synthesis.  Therefore, we inhibited mitochondrial heme synthesis by 
supplementing the embryos medium with SA which inhibits heme biosynthesis by binding to 
ALAD, the second enzyme of the heme synthesis pathway (164) (165).  Incubation of 
zebrafish embryos in embryo medium buffered to pH 7.4 with 2 mM SA did not cause any 
significant defects in RBC hemoglobinization of 3 dpf WT embryos.  However, when the pH 
of embryo medium was allowed to drop to around 3.5, 2 mM SA caused severe anemia in 
comparison to embryos without SA (Fig. 3.24A).  Removal of low pH embryo medium with 
2 mM SA and addition of buffered embryo medium with 2 mM SA (pH 7.4) recovered the 
hemoglobinization after 24 hr (Fig. 3.24B).  The anemia in zebrafish embryos in the acidic 
embryonic medium with 2 mM SA could not be rescued by supplementation of exogenous 
heme, as heme precipitates in acidic condition. 
Since the effects of SA on heme synthesis of zebrafish embryos seems to be a pH-
dependent phenomenon, we sought to genetically block endogenous heme synthesis by 
inhibiting ALAS, the rate-limited enzyme responsible for ALA synthesis.  In mammals, two 
enzymes exist for ALAS: ALAS1 is ubiquitously expressed and ALAS2 is erythroid-specific.  
Zebrafish alas2 was identified by positional cloning of the mutant sauternes (sau) from a 





embryos by injecting Alas2_MO into one-cell embryos from WT and hrg1aiq261/iq261; 
hrg1biq361/iq361 double mutants.  As expected, Alas2_MO caused severe hemoglobinization 
defects as assessed by o-dianisidine staining of 3 dpf embryos (Fig. 3.25).  Surprisingly, 
supplementation of ALA or PBG, the product of ALAS2 in the embryo medium failed to 
rescue the alas2 knockdown.  Additionally, supplementation of 10 µM heme in the embryo 
medium also did not rescue the anemic phenotypes in Alas2_MO morphants in both WT and 
hrg1aiq261/iq261; hrg1biq361/iq361 double mutants (Fig. 3.25).  Together, these results show that 
neither exogenous ALA, PBG or heme rescued heme synthesis defects in zebrafish embryos 






Figure 3.24  SA causes anemia in zebrafish embryos in acidic condition 
A).  O-dianisidine staining of 2 dpf embryos incubated in 2 mM SA for 24 hr in buffered 
(pH7.4) and acidic (pH 3.5) conditions.  Scale bar: 200 µm. 
B).  O-dainisidine staining of 3dpf embryos in normal and acidic conditions with 2 mM SA.  







Figure 3.25  Morpholino knockdown of alas2 causes anemia and cannot be 
rescued by supplementation of heme or its biosynthetic intermediates 
A).  O-dianisidine staining of 3 dpf zebrafish embryos from both WT and hrg1aiq261/iq261; 









In this chapter, we characterized two hrg1 homologs in zebrafish.  Hrg1a and Hrg1b 
are ubiquitously expressed throughout developing embryos with high expression levels in 
nervous system.  Both hrg1a and hrg1b mRNA can be detected in the one-cell stage embryos, 
and hrg1a is highly expressed in the ovary, suggesting that hrg1 may transport maternal heme 
to the developing oocytes to support early embryogenesis before zygotic heme synthesis is 
turned on.  This is possible since zebrafish fpn1 mutant embryos weissherbst (weh) have 
defects in utilizing maternal iron (134).  However, progenies from hrg1aiq261/iq261, 
hrg1biq361/iq361 or hrg1aiq261/iq261; hrg1biq361/iq361 intercrosses have no obvious anemia and 
survive through adulthood without functional Hrg1.  Although the zebrafish genome is almost 
fully sequenced, functional annotation is still ongoing and at least 26% of all genes are 
duplicated due to genome duplication, a process called ohnologues (116).  It is possible that 
Hrg1 may not be the sole pathway for maternal heme delivery to embryos and other genes 
might compensate for the loss of Hrg1 function in early embryos.  Previous studies in 
C.elegans have shown that a small peptide HRG-3 is secreted and functions as a heme 
chaperone for maternal heme delivery to the embryos (166).  Similar mechanisms may exist 
to support early embryogenesis in zebrafish.  Another possibility is that additional Hrg1 
ohnologues may exist in as in C. elegans which possesses four paralogs, hrg-1, -4, -5 and -6.   
We have previously identified HRG-1 as a membrane-bound permease that can bind 
and translocate heme across membranes (69).  Knockdown of zebrafish hrg1a by 
Hrg1a_I2E3_MO2 causes severe anemia with failure in maturation of primitive erythroid 
cells in addition to developmental defects such as hydrocephalus, body axis curvature and 
shortened yolk tube extension.  Our genetic characterizations of hrg1 mutants reveal that 
these phenotypes are only specific to the Hrg1a_I2E3_MO2 based on the following results: 
a).  only a small proportion of hrg1a mRNA is perturbed by Hrg1a_I2E3_MO2 morpholino; 





causes anemia;  c)  injection of Hrg1a_ATG_MO or Hrg1a_E2I2_MO1 which showed 
significant reduction in Hrg1 proteins in hrg1biq361/iq361 mutants, did not cause anemia or 
morphological defects.  We also ruled-out that the phenotypes in Hrg1a_I2E3_MO2 
morphants are due to p53 activation by co-injecting p53_MO (163).  Morpholinos are great 
tools for transient knockdown in animal models such as zebrafish and chick embryos, 
however, off-target effects and chemical toxicity of morpholino can complicate interpretation 
of results from studies using mopholinos (118, 167, 168).  Kok et al reported that 
morpholino-induced phenotypes cannot be recapitulated by mutants generated by gene-
editing tools (169).  They also state that this is consistent with previously published results 
showing that approximately 80 % of morpholino phenotypes cannot be recapitulated in 
mutant embryos from large-scale mutagenesis (170).  It is possible that compensatory 
pathways can buffer against deleterious mutations, an effect typically not observed in 
morpholino knockdown.  Indeed, Rossi et al showed that egfl7 mutants do not show any 
obvious phenotypes compared to morphants because Emilin2 and Emilin3 can compensate 
for loss of Egfl7 (171).  Another study showed that tmem88a-/- mutant embryos partially 
recapitulated but had a much milder phenotype compared to tmem88a morphants (172).  In 
our study, we show that phenotypes associated with hrg1a knockdown by Hrg1a_I2E3_MO2 
cannot be simply attributed to knockdown of hrg1a since other hrg1a specific morpholinos 
and the hrg1a mutant embryos do not show the same phenotypes.  Short sequence BLAST 
showed that Hrg1a_I2E3_MO2 is specific to its targeting site with low homology to other 
sequences.  It is possible that Hrg1a_I2E3_MO2 produce a mis-spliced mRNA which may 
perturb other pathways.  One way to conclusively address this possibility is to delete the 
target site of Hrg1a_I2E3_MO2.  Although we did detect several F0 chimeric founders with 
entire hrg1 gene locus deleted, we were unable to successfully obtain F1 mutants with 





Since the majority of heme is synthesized endogenously, we tried to inhibit heme 
synthesis to recapitulate the heme auxotrophy found in C. elegans, where Hrg1 was 
discovered.  Although SA is widely used to inhibit heme synthesis in cell culture models, it is 
not capable of inhibiting heme synthesis in zebrafish embryos in normal embryonic medium 
unless acidic conditions below pH 4 is used.   
We also tried to inhibit erythropoietic heme synthesis by morpholino knockdown of 
alas2 in WT and hrg1aiq261/iq261; hrg1biq361/iq361 embryos.  However, anemia in alas2 
morphants could not be rescued by either ALA, PBG or heme supplementation, even though 
ALA has been reported to be capable of rescuing ALAS2 mutant embryos with defects in 
heme synthesis (122).  However, it was also reported that ALA fails to rescue ALAS2 
morphants, and high concentration of ALA (1 mM) is toxic to developing embryos (44).   
In summary, our results reveal that Hrg1 is dispensable for maturation and 
hemoglobinization of primitive erythroid cells in zebrafish embryos and genetic studies solely 






Chapter 4:  Hrg1 is involved in heme-iron recycling  
in adult zebrafish 
Summary 
In mouse BMDMs, HRG1 localizes to the erythrophagosome membrane and transports 
heme derived from recycled RBCs into the cytosol.  Depletion of HRG1 by siRNA prevents 
heme-induced upregulation of HMOX1 and FPN1, indicating that HRG1 is upstream from 
these two genes in the heme-iron recycling pathway.  To study the function of Hrg1 in a 
vertebrate animal model, we generated hrg1aiq261/iq261; hrg1biq361/iq361 mutant zebrafish by 
CRISPR/cas9 gene editing.  Although hrg1 mutants are apparently normal in definitive 
erythropoiesis, whole transcriptome sequencing of RNA extracted from the adult spleen and 
kidney revealed large numbers of genes involved in macrophages homeostasis, immune 
response, lipid transport, oxidation-reduction process, and hypoxia are aberrantly expressed 
in the hrg1 mutants.  PHZ induces acute hemolysis in zebrafish with accumulation of iron in 
the spleen and kidney as assessed by DAB-enhanced Perl’s staining.  Both hrg1a and hrg1b 
mRNA were upregulated in zebrafish spleen and kidney upon acute hemolysis concomitant 
with induction of hmox1 and iron accumulation in the spleen, implying that spleen might be 
the predominant site for heme-iron recycling in zebrafish.  Despite a trend of low hmox1 level 
in hrg1aiq261/iq261; hrg1biq361/iq361 double mutants during PHZ-induced hemolysis, the double 
mutant fish did not show significant reduction in hmox1 induction.  Although iron staining 
patterns in the spleen from hrg1 mutants were similar to WT, macrophages from the kidney 
in hrg1 mutants showed aberrant accumulation of iron.  These studies support a model in 






Gene expression profile in adult hrg1 mutants revealed by whole transcriptome 
sequencing 
We hypothesized that if Hrg1 is involved in heme-iron recycling in adults, then there 
might be significant changes in the RNA profile in the RES.  We therefore performed 
RNAseq of RNA from spleens and kidneys of hrg1aiq261/iq261, hrg1biq361/iq361 and 
hrg1aiq261/iq261; hrg1biq361/iq361.  WT fish were crossed to hrg1aiq261/iq261; hrg1biq361/iq361 to 
generate heterozygote hrg1a+/iq261; hrg1b+/iq361 which were used as control.  To minimize 
variations from individual fish, spleens and kidneys from 3 adult zebrafish were dissected and 
pooled for each biological replicate.  Thus, samples from control heterozygotes, 
hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 were sequenced in three 
biological replicates.  False Discovery Rate (FDR) was determined by Benjamini-Hochberg 
with a cutoff of 0.05. 
hrg1 DKO adult zebrafish had no detectable Hrg1 protein by immunoblotting of brain 
samples (Fig. 4.1A).  O-dianisidine and May-Grünwals-Giemsa staining revealed no 
hemoglobinization or morphological defects in circulating RBCs (Fig. 4.1B and C).   
The RNAseq analyzed 24, 220 genes in the zebrafish genome GRCz10 (173).  Overall, 
we found 355 genes in the spleen and 422 genes in the kidney that were differentially 
expressed in hrg1aiq261/iq261; hrg1biq361/iq361 double mutants compared to control.  We also 
compared the transcriptomes of hrg1aiq261/iq261 and hrg1biq361/iq361 which showed 77 genes in 
hrg1aiq261/iq261, and 617 genes in hrg1biq361/iq361 spleen; and 247 genes in hrg1aiq261/iq261, and 
114 genes in hrg1biq361/iq361 kidney that were differentially expressed (Fig. 4.2A).  Clustering 
of the top 30 mis-regulated genes with the greatest statistical significance in hrg1aiq261/iq261, 
hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 for both spleen and kidney revealed different 






Figure 4.1  Hrg1 proteins are absent in hrg1 mutants without defects in 
definitive erythropoiesis 
A).  Hrg1 immunoblot of membrane fraction lysates from brains of Hets, hrg1aiq261/iq261, 
hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361.  Each lane represented 100 µg protein.  
Ponceau is used as a loading control. 
B).  O-dianisidine staining of isolated RBCs from adult zebrafish peripheral blood.  Scale bar: 
20 µm. 
C).  May-Grünwald-Giemsa staining of isolated peripheral RBCs from adult zebrafish 











Figure 4.2  Overview of differentially expressed genes revealed by RNAseq 
A).  The numbers of differentially regulated genes in spleens and kidneys of hrg1aiq261/iq261, 
hrg1biq361/iq361 and double mutant hrg1aiq261/iq261; hrg1biq361/iq361.   
B).  The heat-map clustering of top differentially regulated genes in spleens and kidneys of 
hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361.  The genes were selected 






Detailed examination of RNAseq datasets revealed that expression of 22 genes in 
spleen and 28 genes in kidney were altered in all three mutants (Fig. 4.3A).  Only 4 genes 
were common for the kidney and spleen datasets in all three mutants (Fig. 4.3B).  
Interestingly, among these 4 genes, 2 were downregulated and 2 were upregulated across 
hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 (Fig. 4.3C).  
ENSDARG00000103716 (annotated as MHC II alpha subunit) is the top gene which was 
downregulated across all genotypes.  In mammals, MHC II is highly expressed in neutrophils 
as well as macrophages, including red pulp macrophages (RPMs) which are involved in EP 
(174).  In zebrafish, MHC II is expressed in dendritic cells and T cells with phagocytosis and 
antigen-presentation.  However, whether MHC II is expressed on the surface of macrophages 
in zebrafish is not clear (175, 176).  ENSDARG00000079703 is not well annotated in the 
zebrafish genome.  By sequence alignment, ENSDARG00000079703 encodes an E3 
ubiquitin-protein ligase TRIM38-like protein, which may be important for proteasome 
function.  The INTERPRO protein domain analyses show that it has a SPla/RYanodine 
receptor (SPRY) and butyrophylin-like domain, however, its function is unknown.  
ENSDARG00000090901 encodes a protein which is predicted to be NACHT, LRR and PYD 
domains-containing protein 12 (NALP12).  NALPs are highly expressed in macrophages and 
implicated in the activation of pro-inflammatory caspases within inflammasomes (177).  
Lastly, ENSDARG00000093153 transcribes a 651 nt RNA with no known translated protein , 
as revealed by ENSEMBL database.  Considering that Hrg1 is involved in heme-iron 
recycling by macrophages, the extensive upregulation of NALP12 and downregulation of 












Figure 4.3  Common differentially regulated genes in hrg1 mutants 
A).  Venn diagram of overlapping differentially regulated genes from hrg1aiq261/iq261, 
hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 mutants.  The individual mutants are showed 
with corresponding colors as in the diagram. 
B).  Venn diagram of common differentially regulated genes in both spleens and kidneys of 
hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361. 
C).  Expression level of 4 common differentially regulated genes in spleens and kidneys 






Enrichment analysis of biological processes  
We next determined the gene ontology (GO) of the differentially regulated genes in 
spleens and kidneys from hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 
mutants.  We imported all the differentially regulated genes to DAVID database and analyzed 
the genes with their assigned GO terms (Table 4.1).  Interestingly, the GO term “immune 
response” was the common highly enriched GO term in all six RNAseq datasets.  In the 
kidney datasets for hrg1aiq261/iq261 and hrg1aiq261/iq261; hrg1biq361/iq361, the GO term “transport 
activity” was the most common.  In terms of hrg1aiq261/iq261; hrg1biq361/iq361 double mutants, the 
GO terms oxidation-reduction process, proteolysis, and lipid metabolism were the most 
enriched.  For spleen datasets, lipid transport, oxidation-reduction process together with 
response to hypoxia were highly enriched.  Hrg1 is reported to be upregulated as one of 
hematopoietic targeted genes mediated by NRF2 transcriptional factor during oxidative and 
hypoxic stresses (178).  The enrichment of oxidation-reduction process and response to 
hypoxia implies that Hrg1 may be involved in response to oxidative and hypoxic stress in 
zebrafish.  If HRG1 is highly expressed in macrophages and transports heme out of 
erythrophagosome for heme-iron recycling and the lysis of senescent RBCs involves 
degradation of large amount of proteins and lipids from RBC debris, genes involved in 
immune response, lipid transport and proteolysis may be aberrantly regulated when hrg1 
function is negatively affected.   
We next examined the RNAseq results with KEGG pathways (179).  In the kidney, the 
“metabolic pathways” was the most common term for hrg1aiq261/iq261 and hrg1aiq261/iq261; 
hrg1biq361/iq361.  We did not retrieve a significant KEGG pathway with the RNAseq results of 
kidney from hrg1biq361/iq361.  For the KEGG analysis in regulated genes from spleens, no 





Table 4.  1  Gene ontology enrichment analysis of differentially regulated genes 
in spleens and kidneys of hrg1 mutants 







Kidney    
Differentially regulated genes in hrg1aiq261/iq261 
transport 18 2.15E-02 1.79 
immune response 15 3.53E-07 5.70 
defense response to virus 6 2.36E-05 17.12 
neurotransmitter transport 5 1.09E-03 10.91 
organelle fission 4 2.37E-05 63.59 
gamma-aminobutyric acid transport 4 1.09E-04 40.47 
antigen processing and presentation 4 2.11E-02 6.74 
chemical synaptic transmission 4 9.04E-02 3.74 
amino acid transmembrane transport 3 3.68E-02 9.82 
one-carbon metabolic process 3 3.88E-02 9.54 
biosynthetic process 3 8.37E-02 6.18 
eukocyte migration 2 6.08E-02 31.80 
positive regulation of leukocyte 
chemotaxis 
2 6.08E-02 31.80 
purine nucleobase metabolic process 2 6.92E-02 27.82 
epithelial to mesenchymal transition 2 7.75E-02 24.73 
collagen fibril organization 2 9.39E-02 20.23 
    
Differentially regulated genes in hrg1biq361/iq361 
immune response 4 7.49E-02 3.99 
organelle fission 3 2.29E-04 125.31 
defense response to virus 3 7.54E-03 22.49 
cell chemotaxis 3 1.13E-02 18.27 
inflammatory response 3 8.11E-02 6.22 
innate immune response 3 9.52E-02 5.66 
neutrophil migration 2 1.67E-02 116.96 
    
Differentially regulated genes in hrg1aiq261/iq261; hrg1biq361/iq361 
transport 30 8.36E-03 1.64 
oxidation-reduction process 26 2.39E-05 2.59 
immune response 16 9.05E-05 3.35 
proteolysis 16 2.59E-02 1.86 
lipid transport 13 1.18E-09 11.40 





neurotransmitter transport 6 1.38E-03 7.22 
cellular response to estrogen stimulus 5 7.64E-04 11.80 
purine nucleobase metabolic process 4 2.23E-04 30.68 
lipoprotein metabolic process 4 5.88E-03 10.67 
heterophilic cell-cell adhesion via plasma 
membrane cell adhesion molecules 
4 2.19E-02 6.63 
gamma-aminobutyric acid transport 3 1.31E-02 16.74 
aromatic amino acid family metabolic 
process 
3 1.56E-02 15.34 
triglyceride catabolic process 3 1.56E-02 15.34 
arachidonic acid metabolic process 3 1.82E-02 14.16 
cell recognition 3 7.06E-02 6.82 
chemokine-mediated signaling pathway 3 9.47E-02 5.75 
negative regulation of macrophage 
activation 
2 3.22E-02 61.37 
lipoprotein catabolic process 2 4.79E-02 40.91 
complement activation 2 7.86E-02 24.55 
response to estradiol 2 7.86E-02 24.55 
response to retinoic acid 2 7.86E-02 24.55 
regulation of immune response 2 7.86E-02 24.55 
hyaluronan metabolic process 2 7.86E-02 24.55 
hydrogen ion transmembrane transport 2 9.35E-02 20.46 
    
Spleen    
Differentially regulated genes in hrg1aiq261/iq261 
lipid transport 6 1.47E-07 45.65 
immune response 6 1.60E-04 10.91 
cellular response to estrogen stimulus 2 4.61E-02 40.97 
cell recognition 2 4.78E-02 39.45 
heterophilic cell-cell adhesion via plasma 
membrane cell adhesion molecules 
2 6.49E-02 28.79 
    
Differentially regulated genes in hrg1biq361/iq361 
transport 38 2.85E-02 1.41 
oxidation-reduction process 29 8.95E-04 1.96 
immune response 17 1.91E-03 2.42 
cell adhesion 13 8.14E-02 1.70 
heart development 11 1.11E-02 2.56 
heart looping 10 1.38E-03 3.75 
cellular response to estrogen stimulus 9 1.07E-07 14.42 
heart contraction 9 1.09E-04 6.05 





inflammatory response 8 5.30E-02 2.36 
skeletal muscle tissue development 7 9.48E-04 6.07 
regulation of cell proliferation 7 6.85E-02 2.43 
embryonic heart tube development 6 1.78E-03 6.75 
antigen processing and presentation 6 2.08E-02 3.79 
gluconeogenesis 5 9.42E-04 10.96 
myofibril assembly 5 9.42E-03 5.95 
hindbrain development 5 2.07E-02 4.73 
single organismal cell-cell adhesion 5 2.94E-02 4.25 
response to lipopolysaccharide 5 3.14E-02 4.17 
striated muscle contraction 4 5.35E-05 41.65 
blood coagulation, fibrin clot formation 4 1.31E-04 33.32 
cardiac muscle contraction 4 9.92E-03 8.77 
skeletal muscle contraction 4 1.15E-02 8.33 
regulation of heart contraction 4 2.60E-02 6.17 
glycolytic process 4 5.07E-02 4.76 
blood coagulation 4 8.79E-02 3.79 
protein polymerization 3 1.69E-03 41.65 
ventricular cardiac myofibril assembly 3 3.32E-03 31.24 
cardiac muscle fiber development 3 5.45E-03 24.99 
cardiac myofibril assembly 3 8.04E-03 20.83 
positive regulation of leukocyte 
chemotaxis 
3 1.11E-02 17.85 
platelet activation 3 2.27E-02 12.50 
cardiac muscle tissue development 3 2.73E-02 11.36 
multicellular organismal response to stress 3 2.73E-02 11.36 
aromatic amino acid family metabolic 
process 
3 3.22E-02 10.41 
response to xenobiotic stimulus 3 3.75E-02 9.61 
cardiac muscle cell proliferation 3 4.30E-02 8.93 
muscle contraction 3 7.48E-02 6.58 
oxygen transport 3 7.48E-02 6.58 
atrial cardiac myofibril assembly 2 4.73E-02 41.65 
fibrinolysis 2 4.73E-02 41.65 
tryptophan catabolic process to acetyl-CoA 2 4.73E-02 41.65 
bile acid biosynthetic process 2 4.73E-02 41.65 
tryptophan catabolic process to kynurenine 2 7.01E-02 27.77 
cornea development in camera-type eye 2 7.01E-02 27.77 
ventricular cardiac muscle tissue 
morphogenesis 
2 7.01E-02 27.77 
cell proliferation in hindbrain 2 9.24E-02 20.83 





Differentially regulated genes in hrg1aiq261/iq261; hrg1biq361/iq361 
immune response 8 7.45E-02 2.18 
dorsal/ventral pattern formation 7 2.55E-03 5.07 
defense response to virus 6 1.17E-04 12.27 
response to hypoxia 5 4.26E-03 7.52 
response to virus 3 1.66E-02 14.95 
insulin receptor signaling pathway 3 2.78E-02 11.39 
growth 3 8.12E-02 6.30 
positive regulation of pathway-restricted 
SMAD protein phosphorylation 
3 8.87E-02 5.98 
SMAD protein signal transduction 3 9.64E-02 5.70 
intrinsic apoptotic signaling pathway in 
response to endoplasmic reticulum stress 
2 4.90E-02 39.87 
regulation of lipid metabolic process 2 8.41E-02 22.78 






Table 4.  2  Enrichment of KEGG pathways of differentially regulated genes in 








Kidney    
Differentially regulated genes in hrg1aiq261/iq261 
Metabolic pathways 16 1.39E-02 1.81 
Cysteine and methionine metabolism 3 3.57E-02 9.75 
    
Differentially regulated genes in hrg1aiq261/iq261; hrg1biq361/iq361 
Metabolic pathways 29 7.51E-05 2.01 
Purine metabolism 6 6.10E-02 2.77 
Arachidonic acid metabolism 4 1.91E-02 6.87 
Steroid hormone biosynthesis 4 7.97E-03 9.48 
Cysteine and methionine metabolism 4 1.29E-02 7.97 
Ubiquinone and other terpenoid-quinone 
biosynthesis 
3 5.26E-03 26.29 
Linoleic acid metabolism 3 2.27E-02 12.52 
Tyrosine metabolism 3 5.24E-02 7.97 
Phenylalanine metabolism 3 1.34E-02 16.43 
Intestinal immune network for IgA 
production 
3 7.37E-02 6.57 
Glycine, serine and threonine metabolism 3 9.03E-02 5.84 
    
Spleen    
Differentially regulated genes in hrg1aiq261/iq261 
Intestinal immune network for IgA 
production 
2 4.34E-02 38.81 
    
Differentially regulated genes in hrg1biq361/iq361 
Adrenergic signaling in cardiomyocytes 10 3.08E-02 2.26 
Tight junction 9 4.30E-02 2.26 
Cardiac muscle contraction 8 5.29E-03 3.71 
Glycolysis / Gluconeogenesis 7 5.43E-03 4.27 
Insulin resistance 7 7.54E-02 2.34 
PPAR signaling pathway 6 1.72E-02 3.93 
Biosynthesis of amino acids 6 4.03E-02 3.14 
Drug metabolism - other enzymes 5 7.95E-03 6.19 
Pentose phosphate pathway 4 3.08E-02 5.75 





Phenylalanine metabolism 3 4.81E-02 8.35 
    
Differentially regulated genes in hrg1aiq261/iq261; hrg1biq361/iq361 
Insulin signaling pathway 6 3.12E-02 3.33 
TGF-beta signaling pathway 5 1.85E-02 4.81 
Insulin resistance 5 4.74E-02 3.58 
FoxO signaling pathway 5 9.70E-02 2.80 
Phenylalanine metabolism 3 1.14E-02 17.88 
Tyrosine metabolism 3 4.49E-02 8.67 
ABC transporters 3 5.26E-02 7.94 
Intestinal immune network for IgA 
production 
3 6.34E-02 7.15 
Phenylalanine, tyrosine and tryptophan 
biosynthesis 
2 6.03E-02 31.78 
Ubiquinone and other terpenoid-quinone 
biosynthesis 







PHZ causes acute hemolysis in zebrafish embryos 
Hrg1 localizes to the membrane of erythrophagosomes during heme-iron recycling by 
EP and mediates heme transport from the erythrophagosome to the cytosol for heme 
degradation in primary mouse BMDMs (92).  Zebrafish Hrg1a and Hrg1b are close homologs 
to mouse and human HRG1 with ~80% homology and similar topology.  Therefore, we 
postulated that Hrg1 may have a similar role in heme-iron recycling in the reticuloendothelial 
organs of the zebrafish.  PHZ is a strong hemolytic chemical toxicant, causing acute 
hemolysis in embryonic and adult zebrafish (137, 180). 
We first determined the function of Hrg1 in possible heme-iron recycling during 
definitive erythropoiesis at the larval stage by exposing 4 dpf embryos to PHZ because at this 
stage definitive erythrocytes appear in the circulation.  O-dianisidine staining found no overt 
deficiencies in staining levels among WT, hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; 
hrg1biq361/iq361.  Exposure to PHZ caused depletion of o-dianisidine positive RBCs in the 
circulation (Fig. 4.4A).  We then removed the PHZ from the embryo medium to assess the 
recovery of definitive RBCs in the circulation.  At 3 days post-PHZ treatment, o-dianisidine 
positive RBCs started to repopulate the circulation; however, no significant differences in the 
recovery of definitive RBCs were observed among WT, hrg1aiq261/iq261, hrg1biq361/iq361 and 






Figure 4.4  PHZ causes depletion of o-dianisidine positive RBCs in 4 dpf 
zebrafish embryos 
A).  O-dianisidine staining of 4 dpf embryos from WT, hrg1aiq261/iq261, hrg1biq361/iq361 and 







Figure 4.5  Recovery of definitive erythrocytes at 3 days post-PHZ treatment 
A).  O-dianisidine staining of 7 dpf embryos from WT, hrg1aiq261/iq261, hrg1biq361/iq361 and 








Zebrafish hrg1a and hrg1b are upregulated during acute hemolysis induced by 
PHZ 
To study heme-iron recycling in adult zebrafish, we used PHZ to cause acute hemolysis 
and induce EP in the adult zebrafish RES.  Adult zebrafish (5-6 months) were treated with 2 
µg/ml PHZ directly in fish water for 30 min.  At 1 day post-PHZ treatment, we isolated 
spleen, kidney and liver for RNA extraction and qRT-PCR.  PHZ-treated zebrafish revealed 
greatly enlarged spleen with a dark brown color, suggesting active EP to clear the damaged 
RBCs.  The kidney and livers were pale compared to the untreated controls.  The 
gastrointestinal cavity accumulated large amounts of green substances which could be 
bilirubin, a heme degradation byproduct.  qRT-PCR revealed that hrg1a and hrg1b mRNA 
expression were upregulated in the kidneys, the major adult hematopoietic tissue, with 2.8 
and 3.6-fold, respectively (p < 0.05, t-test) (Fig 4.6A).  While hrg1a is 5 times upregulated in 
the spleen (p < 0.05, t-test), expression of hrg1b mRNA is not significantly upregulated (p = 
0.4, t-test) (Fig 4.6B).  We did not detect any significant changes in hrg1a or hrg1b 
expression in the liver (Fig 4.6C).  As expected, hmox1 mRNA was greatly upregulated in 
the kidney, spleen and liver, upon PHZ treatment (p < 0.05, t-test) (Fig 4.6D), implying that 
these tissues could play a role in heme breakdown.  Comparison of hmox1 expression levels 
in the kidney, spleen, and liver reveals that the spleen has the highest expression of hmox1 (p 
< 0.0001, t-test) (Fig 4.6D).  Based on the upregulation of hmox1 and hrg1, it is possible that 
the kidney and spleen may be the most active tissues for RBC degradation in the adult 
zebrafish. 
We next performed DAB-enhanced iron staining on histological sections from PHZ-
treated adult zebrafish.  Large amount of iron accumulated in the kidney and spleen, with no 







Figure 4.6  Hrg1 mRNA is upregulated upon acute hemolysis induced by PHZ 
A).  qRT-PCR of hrg1a and hrg1b mRNA expression in kidneys from control (non-PHZ 
treatment) and 1 day post-PHZ treatment adult zebrafish. 
B).  qRT-PCR of hrg1a and hrg1b expression in spleens from control (non-PHZ 
treatment) and 1 day post-PHZ treatment adult zebrafish. 
C).  qRT-PCR of hrg1a and hrg1b expression in livers from control (non-PHZ treatment) 
and 1 day post-PHZ treatment adult zebrafish. 
D).  Comparison of hmox1 mRNA level in kidneys, spleens and livers from control (non-
PHZ treatment) and 1 day post-PHZ treatment adult zebrafish. 
Statistical analysis: Multi-t test.  *: p-value < 0.05; **: p-value < 0.01; ****: p-value < 
0.0001 
Relative expressions are normalized to ef1a as reference gene.  Each group have 3 







Figure 4.7  Iron is accumulated in kidney and spleen upon PHZ treatment 
A).  DAB-enhanced Perl’s iron staining on kidney, spleen, and liver sections.  Adult 
zebrafish were treated with PHZ, then fixed and sectioned 3 days after PHZ treatment.  
DAB enhanced Perl’s staining were showed on sectioned slides with brown staining.  






Delineating heme-iron recycling during hemolysis in hrg1 mutant zebrafish 
Macrophages are predominantly involved in heme-iron recycling during EP and defects 
in HRG1 causes failure in upregulation of HMOX1 in mouse BMDMs with accumulation of 
heme in the erythrophagosome (92).  We therefore delineated whether hrg1aiq261/iq261; 
hrg1biq361/iq361 mutants are defective in heme-iron recycling when challenged with PHZ.  qRT-
PCR on mRNA from kidneys and spleens of adult zebrafish at 1 day post-PHZ treatment 
revealed no significant differences in hmox1 mRNA induction between double heterozygotes 
(Hets), hrg1aiq261/iq261, hrg1biq361/iq361 and hrg1aiq261/iq261; hrg1biq361/iq361 mutants, although there 
was a trend for hmox1 mRNA was to be lower in the double mutant (Fig. 4.8A).  At 3 days 
post-PHZ treatment, hmox1 expression is lower in the kidney of hrg1aiq261/iq261; hrg1biq361/iq36 
(p < 0.05, t-test), but not in the spleen (Fig. 4.8B).  Histological analysis with DAB-enhanced 
Perl’s staining reveals no obvious differences in iron accumulation in the spleen at 3 days 
post-PHZ treatment (Fig. 4.9A).  However, Perl’s staining revealed that unlike the WT 
kidney which showed iron accumulation in both renal tubules and macrophages, the double 
mutant showed iron staining predominantly localized in renal tubules in the hrg1aiq261/iq261; 
hrg1biq361/iq361 (Fig. 4.9B).  This result suggests that in the absence of functional Hrg1, the 







Figure 4.8  Expression of hmox1 upon PHZ treatment 
A).  qRT-PCR of hmox1 mRNA in spleen and kidney at 1day post-PHZ treatment. 
B).  qRT-PCR of hmox1 mRNA in spleen and kidney at 3day post-PHZ treatment. 
Statistical analysis: t-test.  *: p < 0.05.  Relative expressions are normalized to ef1a as 








Figure 4.9  Iron is accumulated in kidney and spleen after PHZ treatment. 
A).  DAB-enhanced Perl’s iron staining on kidneys of WT and hrg1aiq261/iq261; hrg1biq361/iq361 
at 3 days post-PHZ treatment.  Scale Bar: 200 µm. 
B).  DAB-enhanced Perl’s iron staining on spleens of WT and hrg1aiq261/iq261; hrg1biq361/iq361 at 






In this chapter, we aimed to delineate the function of Hrg1 in heme-iron recycling of 
adult zebrafish.  First, we disrupted primitive erythrocytes by PHZ and found that the 
recovery of circulating definitive RBCs are the same between WT and mutants.  Whether any 
heme-iron recycling occurs in the developing embryos is unclear, for the following reasons: 
a)  zebrafish embryos retain large amount of maternal iron for embryogenesis and fpn1 is 
proposed to transport maternal iron to the developing embryos (134);  and b)  zebrafish 
merlot (mot) mutants with hemolytic anemia seem to get rid of heme and degradation 
products from hemolysis of primitive RBCs into the bile as dark pigments during early 
embryogenesis without undergoing recycling (181).  We have also detected the same dark 
pigment around the yolk extension tube of PHZ-treated embryos.  Thus, a heme-iron 
recycling system might not be required or in existence in early embryos.   
However, mot mutants can survive to adulthood and adult mutants suffer from 
prominent phenotypes including enlarged spleen, and hypercellular kidneys with high 
bilirubin levels, a byproduct of heme catabolism, suggesting an active heme-iron recycling 
pathway in adult fish (181).  It also has been shown that fpn1, an iron exporter, is critical in 
iron recycling during adult erythropoiesis, and mutation in fpn1 causes iron accumulation in 
the macrophages of liver and kidney (135).  The zebrafish kidney marrow is the major 
hematopoietic tissue and the spleen is a niche for EP (114, 115).  It is noteworthy that Hrg1a 
and Hrg1b is relatively highly expressed in the kidney marrow and spleen, thus it is possible 
that zebrafish Hrg1 is involved in adult heme-iron recycling during definitive erythropoiesis 
or in stressed conditions such hemolysis.  Indeed, RNAseq results suggest a possible defect in 
macrophage function and consequently immune response in the hrg1 mutant fish.  Moreover, 
since there may be a disruption in recycling damaged RBCs, which involves catabolism of 
large amount of proteins and lipids from RBCs, gene expression of proteolysis and lipid 





Hrg1a and hrg1b mRNA are upregulated in zebrafish kidney upon PHZ-induced 
hemolysis.  Similar upregulation also occurs in the spleen for hrg1a.  Zebrafish spleen is 
relatively tiny, and the size and morphology varies in adult zebrafish.  Although we used 3 
biological replicates and each replicate contain 3 adult spleen, the variation in qPCR results is 
still large.  Zebrafish kidney and spleen are the predominant sites for heme-iron recycling, 
based on the following facts: a)  PHZ causes iron accumulation in the spleen and kidney as 
shown by DAB-enhance Perl’s staining; and b)  hmox1 shows high upregulation during 
hemolysis.  Further studies with hrg1aiq261/iq261; hrg1biq361/iq361 is necessary to establish 











Chapter 5: MRP5/ABCC5, a heme exporter, and its paralog 
MRP9/ABCC12 alter zebrafish erythropoiesis 
Summary 
Using C.elegans as an animal model of heme auxotroph, we have previously showed 
that mrp-5 is a heme exporter expressing on the basolateral membranes of the worm’s 
intestine.  Zebrafish mrp5/abcc5 is the ortholog of C.elegans mrp-5.  We have previously 
shown that zebrafish Hrg1 paralogs (hrg1a and hrg1b) can rescue the growth of hem1Δ strain 
in the presence of low heme, indicating that they are bone fide heme importers.  In this 
chapter, we show that zebrafish Mrp5 is capable of transporting heme.  Expression of 
zebrafish mrp5 decreases growth of hem1Δ yeast, suggesting that heme is transported out of 
yeast by zebrafish Mrp5.  WISH reveals that zebrafish mrp5 is ubiquitously expressed 
throughout the developing embryo with high expression in the central nervous system.  
Morpholino knockdown of mrp5 in zebrafish shows severe anemia in developing embryos 
with loss of gata1 expression, a transcription factor for erythroid specification.  Additionally, 
anemic phenotypes in mrp5 morphants can be rescued by co-injection of in-vitro transcribed 
recoded mrp-5 capped RNA, indicating that zebrafish Mrp5 is necessary for erythropoietic 
development.  Unlike two paralogs (ohnologues) for hrg1 in zebrafish genome, the closest 
homolog of mrp5 is mrp9/abcc12 by multiple sequence alignment and phylogenetic analysis.  
Yeast growth assay revealed that both zebrafish Mrp5 and Mrp9 are capable of heme export.  
Mrp9 mRNA is ubiquitously expressed in zebrafish embryos at different developing stages 
and maternal mrp9 mRNA is deposited into oocytes.  Similar to mrp5, knockdown of abcc12 
in zebrafish also causes anemia and loss of hemoglobinized RBCs.  These results suggest that 
both mrp5 and mrp9 are required for RBC development in zebrafish embryos.  Subsequent 
generation and characterization of mrp5 and mrp9 mutants by CRISPR/Cas9 gene editing 






Expression of Zebrafish Mrp5 alters heme homeostasis in a heterologous yeast 
system 
Zebrafish mrp5/abcc5 is located across ~56kb on chromosome 18 in the zebrafish 
genome, with overall 28 exons encoding a 1,426 aa protein (Fig. 5.1A).  Like the canonical 
multidrug resistant protein (MRP), zebrafish Mrp5 contains 12 transmembrane domains and 2 
nucleotide binding domains (NBD) with ATP-hydrolysis activity for energy-driven substrate 
transport.  To determine whether zebrafish Mrp5 transports heme, we exploited the well-
established assays in yeast.  Expression of C. elegans heme importers HRG-4 (CeHRG-4) or 
HRG-1 (CeHRG-1) increases yeast growth compared to control yeast grown on heme-
supplemented plates (Fig. 5.1B).  When hem1Δ yeast cells express the C.elegans heme 
exporter, CeMRP-5, their growth is reduced compared to control group.  Similarly, the 
growth of hem1Δ yeast expressing zebrafish Mrp5 (ZfMrp5) is decreased in the presence of 
heme (Fig. 5.1B), suggesting that Mrp5 is decreasing intracellular heme and therefore 








Figure 5.1  Expression of zebrafish Mrp5 reduces growth of heme deficient 
yeast stain in the presence of exogenous heme 
A).  Structure of mrp5 in its gene locus on chromosome 18.  Exons are shown as brown 
boxes and introns are shown as lines.  The overall length of zebrafish mrp5 gene is ~56kb. 
B).  Inhibition of yeast growth by zebrafish Mrp5 when expression in mutant hem∆1 strain.   
The hem1Δ yeast strain was transformed with indicated constructs and grown overnight in 
SC medium without ALA and spotted in serial dilutions on 2 % raffinose SC (-Ura, +0.4 % 
galactose) plates supplemented with indicated concentrations of ALA or hemin.  Plates 





Expression of zebrafish mrp5/abcc5 in developing zebrafish embryos 
RT-PCR of total mRNA extracted from embryos at single cell stage to 4 dpf showed 
that mrp5 mRNA is not expressed in the early stage embryos but only after 18 hpf (Fig. 
5.2A).  To determine the temporospatial expression profile of mrp5 mRNA in zebrafish 
embryos, we generated anti-sense RNA probe and WISH analysis revealed that mrp5 mRNA 
is ubiquitously expressed all through the developing embryo with greater expression in the 







Figure 5.2  Expression of mrp5 in developing zebrafish embryos 
A).  RT-PCR of mrp5/abcc5 in embryos at different developmental stages.  ß-actin is the 
control for house-keeping gene; cbfb, an established transcription factor which is only 
turned on around 18 hpf. 
B).  WISH of mrp5/abcc5 in embryos at different developmental stages.  Anterior is to the 
left.  Anti-sense probe is used to detect mRNA expression; sense probe is shown to 





Mopholino knockdown of mrp5 in zebrafish embryos causes severe anemia and 
developmental defects 
To knockdown mrp5/abcc5, we injected fish embryos with morpholinos specifically 
targeting against the ATG start codon of mrp5/abcc5 (mrp5_MO) mRNA.  Embryos injected 
with mrp5_MO show severe anemia with few o-dianisidine-positive RBCs compared to 
embryos injected with control_MO (Fig. 5.3A).  Mrp5_MO morphants also exhibited 
developmental malformations including body axis curvature defects and enlarged hearts.  To 
quantify the severe anemia phenotype, we compared levels of globin-expressing RBCs in the 
control_MO and mrp5_MO morphants.  Transgenic zebrafish expressing GFP from the 
globin locus control region (globinLCR:GFP) were injected with either control_MO or 
mrp5_MO morpholinos, and the blood was analyzed 2 dpf embryos for GFP expression.  
Zebrafish embryos injected with mrp5_MO showed significantly less GFP-positive RBCs 
compared to control_MO morphants (Fig 5.3B).  The mrp5_MO anemia is indeed due to 
Mrp5/Abcc5 deficiency, as co-injecting zebrafish embryos with mrp5/abcc5 capped mRNA 
(cRNA) significantly corrected the anemia phenotype (Fig 5.3C).  Taken together, these data 
indicate that mrp5 is critical for zebrafish erythropoiesis, and that MRP5 regulation of 
systemic heme homeostasis is likely conserved from worms to vertebrates. 
To further confirm the anemic phenotype, we used another splice-blocking morpholino 
targeting the intron-exon junction of exon 26.  Similar to translation blocking morpholino 
mrp5_MO, Mrp5_E26_MO also resulted in significantly higher portion of morphants with 
anemia, suggesting that the anemic phenotypes are likely due to mrp5 knockdown (Fig. 5.4A 
and B).  RT-PCR analysis revealed that Mrp5_E26_MO morphants expressed a mis-spliced 











Figure 5.3  Morpholino knockdown of mrp5 alters zebrafish erythropoiesis. 
A).  Knockdown of zebrafish mrp5 using morpholinos (mrp5_MO) results in severe anemia, 
as indicated by reduced staining of o-dianisidine-positive red cells.   
B).  Knockdown of zebrafish mrp-5 using mrp5_MO results in reduced red cell formation.  
Transgenic embryos expressing GFP from the globinLCR: GFP were injected with 
control_MO or mrp5_MO.  LEFT: On 3 dpf, percent GFP-positive RBCs was analyzed by 
FACS.  X and Y axes measure GFP and forward scatter, respectively; boxed area indicates 
gate for RBCs.  RIGHT: Quantification of morphants shown at left.  For Mrp5_MO injection, 
error bars indicate SEM of four independent experiments.  ***P<0.001 for Mrp5_MO 
morphants compared to control morphants under identical conditions.  (One-way ANOVA, 
Tukey post-tests.). 
C).  O-dianisidine staining and quantification of anemia rescue in zebrafish embryos co-
injected with mrp5 cRNA.  For Mrp5_MO injection, error bars indicate SEM of four 
independent experiments.  ***P<0.001 for Mrp5_MO morphants compared to control 
morphants under identical conditions.  For Mrp5_MO co-injection with rescue mRNA, error 
bars indicate SEM of three independent experiments.  **P<0.01 for mrp5 morphants co-
injected with rescue mRNA when compared to mrp5 morphants with no rescue mRNA under 







Figure 5.4  Knockdown of mrp5 by splice-blocking morpholino alters zebrafish 
erythropoiesis. 
A).  Knockdown of zebrafish mrp5 using mrp5_E26_MO results in severe anemia, as 
indicated by reduced staining of o-dianisidine-positive red cells.   
B).  Quantification of anemic embryos in control_MO or mrp5_E26_MO. 
C).  RT-PCR of control_MO and mrp5_E26_MO for mrp5 expression.  Red arrow shows the 






Mrp5 knockdown results in deficiency in erythroid specification  
To investigate whether the anemic phenotypes of mrp5 morphants are due to 
differentiation of erythroid progenitor cells or RBC maturation, we perform WISH on gata1, 
a transcription factor required for primitive erythropoiesis in zebrafish.  While gata1 mRNA 
was robustly expressed in WT embryos and control_MO morphants, positive gata1 staining 
was rarely observed in the mrp5_MO morphants (Fig. 5.5A).  We also injected mrp5_MO to 
gata1: GFP transgenic embryos, in which GFP expression is driven by gata1 promoter.  
Knockdown of mrp5 causes gata1: GFP to be significantly impaired (Fig. 5.5A).  These 
results suggest that the anemic phenotypes in the mrp5_MO morphants are due to defects in 






Figure 5.5  Knockdown of mrp5 results in loss of gata1 expression in zebrafish 
embryos 
A).  Lateral view of zebrafish embryos in WT, control MO, and Mrp5_MO morphants by 
whole mount in situ hybridization using anti-sense gata1 probe or gata1:GFP at 24 hpf.  







Mrp9/Abcc12 is a functional homolog of Mrp5/Abcc5 
Multiple sequences alignment and phylogenetic analysis reveal that mrp5/abcc5, and 
has another close homolog mrp9/abcc12 in zebrafish, mouse and human genome (Fig. 5.6A).  
Zebrafish mrp9/abcc12 is located in chromosome 16 spanning 26 kb with 31 exons encoding 
a 1,368 aa protein (Fig. 5.6B).  Zebrafish Mrp9 also contains 12 transmembrane domains and 
two nucleotide-biding domains with ATP-hydrolysis activity.   
To assess the heme transport activity of zebrafish Mrp9, we performed the yeast growth 
assay in hem1∆ mutant.  Similar to expression zebrafish Mrp5, expression of zebrafish Mrp9 
retards the growth of hem1∆ yeast suggesting that both Mrp5 and Mrp9 could be potential 






Figure 5.6  Mrp9/Abcc12 is a functional homolog to Mrp5/Abcc5 
A).  Phylogenetic analysis of MRP5/ABCC5 clade in C. elegans, zebrafish, mice, and 
humans.  Sequences were aligned using ClustalW2 and a phylogenetic tree was generated 
using the Neighbor-Joining method in MEGA5.   
B).  Structure of mrp9 in its gene locus on chromosome 16..  Exons are showed as brown 
boxes and introns are shown as lines.  The overall length of zebrafish mrp9 gene is ~27kb. 
C).  Inhibition of yeast growth by zebrafish Mrp9 when expression in hem∆1 strain.   
The hem1Δ yeast strain was transformed with indicated constructs and grown overnight in SC 
medium without ALA and spotted in serial dilutions on 2 % glycerol-lactate (-Ura, +0.4 % 
galactose for induction before plating) plates supplemented with indicated concentrations of 





RNA expression of zebrafish mrp9/abcc12 in developing zebrafish embryos 
To determine the localization of mrp9/abcc12 expression, total mRNA was extracted 
from one-cell stage to 4 dpf.  Compared to its homolog mrp5/abcc5, RT-PCR analysis 
revealed that mrp9 mRNA is maternally deposited in the developing embryos (Fig. 5.7A).  
WISH analysis using anti-sense RNA probe for abcc12 mRNA revealed that mrp9 mRNA is 
ubiquitously expressed all over the developing embryos with strong expression in the central 
nervous system, but unlike mrp5, mrp9 showed strong staining in the early stage embryos, 






Figure 5.7  Expression of mrp9 in developing zebrafish embryos. 
A).  Semi-quantitative RT-PCR of mrp9/abcc12 in embryos at different developmental 
stages.  ß-actin is the control for house-keeping gene; cbfb, an established transcription factor 
which is only turned on around 18 hpf. 
B).  WISH of mrp5 expression in embryos at different stages.  Anterior is to the left.  Anti-








Mopholino knockdown of mrp9/abcc12 in zebrafish embryos causes anemia  
To knockdown mrp9/abcc12, zebrafish embryos were injected with morpholinos 
targeting against either the ATG start codon (abcc12_ATG_MO) or exon-intron junction 
(abcc12_E29_MO) of mrp9/abcc12 mRNA.  Knockdown of mrp9/abcc12 by both 
abcc12_ATG-MO and abcc12_E29_MO revealed few o-dianisidine positive RBCs compared 
to embryos injected with control_MO (Fig. 5.8A).  Quantification of injected embryos 
revealed a significant number of mrp9 morphants is anemic compared to control_MO 
morphants (Fig. 5.8B).  RT-PCR analysis showed that abcc12_E29_MO morphants express a 
misspliced form of mrp9/abcc12 mRNA as a larger-size PCR product was detected.  
Subsequent DNA sequencing of this product revealed that abcc12_E29_MO blocked splicing 
thereby causing retention of exon 29 in the morphants (Appendix VI) (Fig. 5.8C).  These 
data collectively indicate that, similar to mrp5/abcc5, zebrafish mrp9/abcc12 is necessary for 






Figure 5.8  Knockdown of mrp9/abcc12 alters zebrafish erythropoiesis 
A).  Morpholino knockdown of zebrafish mrp9/abcc12 results in severe anemia, as indicated 
by reduced staining of o-dianisidine-positive red cells.   
B).  Quantification of anemic embryos in control_MO or mpr9/abcc12 morphants. 
C).  RT-PCR of control_MO and abcc12_E29_MO for mrp9 expression.  Red arrow shows 







Mrp5 (ABC-transports subfamily C) has been extensively studied as an exporter of 
cancer drugs, organic anions and nucleoside metabolites.  However, the physiological 
substrates for Mrp5 are unknown (182).  Here we show that zebrafish mrp5 is widely 
expressed during early zebrafish development and that loss of Mrp5 leads to severe anemia 
and developmental defects.  We also show that zebrafish Mrp5, and human MRP5 inhibit 
heme-dependent growth when expressed in the hem1Δ yeast mutant. 
By using subcellular HRP heme reporters, our lab previously showed that both C.  
elegans MRP-5 and human MRP5 reduces heme availability in the cytosol with a 
concomitant increase in heme availability in the secretory pathway (64).  When expressed in 
yeast, both worm and human MRP5 localizes to intracellular membranes which are distinct 
from the vacuole or plasma membrane (64).  These results suggest that MRP5 proteins are 
capable of transporting heme from the cytosol into the secretory pathway in yeast.  Results 
from yeast growth assays indicate that zebrafish Mrp5 is capable of mediating heme transport 
and is comparable to the C.elegans and human MRP-5.  It is therefore reasonable to predict 
that zebrafish Mrp5 may also localize to intracellular membranes and efflux heme into 
secretory pathway. 
Mouse and Human Mrp5 are ~39 % identical to C. elegans MRP-5, while zebrafish 
Mrp5 is ~74 % identical to mammalian MRP5.  Morpholino knockdown of mrp5 results in 
severe anemia and developmental defects, which can be specifically rescued by co-injection 
with recoded zebrafish mrp5 mRNA.  Loss of the erythropoietic-specific transcription factor 
in mrp5 morphants indicates that mrp5 is required for specification of RBCs.  While the 
mechanism whereby loss of mrp5 results in anemia remains unknown, these results suggest 
that heme transport plays a critical role in early development and erythropoiesis in zebrafish. 
Multiple sequences alignments and phylogenetic identify another member of ABC-





growth of hem1∆ yeast mutants.  Both mrp5 and mrp9 mRNA are widely expressed in the 
zebrafish embryo.  Interestingly, unlike mrp5, mrp9 mRNA is maternally deposited to 
zebrafish embryos, suggesting its possible role in maternal heme delivery.  Knockdown of 
Mrp9 in zebrafish embryos also caused anemic phenotypes.  Further experiments are 
necessary to elucidate the subcellular localization of Mrp9 and the underlying mechanism of 
anemia in mrp9 morphants. 
One caveat is that we have not measured direct heme transport by Mrp5 and it is 
possible that the heme-dependent phenotypes are indirect.  Since Mrp5 and Mrp9 localize to 
subcellular compartments, it is difficult to measure heme transport at a subcellular level.  
Expression of Mrp5 and Mrp9 in a reconstituted membrane system may permit transport 
measurement.   
Our functional studies for Mrp5 and Mrp9 are based on heterologous expression and 
morpholino knockdown.  While morpholino is a good tool for gene knockdown, it is possible 
that there could be off-target effects.  Current studies are being conducted with CRISPR/Cas9 
to generate null alleles for mrp5 and mrp9 in zebrafish and in mice, to further functionally 






Chapter 6:  Conclusions and future directions 
Conclusions 
Heme and iron metabolism are closely intertwined to maintain homeostasis and our 
results reveal that heme transporters significantly contribute to regulate intercellular and 
intracellular heme levels.  HRG1 and MRP5 were identified as heme importer and exporter, 
respectively, using the power of C. elegans genetics.  The objective of the current study was 
to dissect the function of heme transporters in red-cell development and heme-iron recycling 
by exploiting zebrafish as an in vivo vertebrate animal model.  The major findings of this 
study are listed and discussed as follows: 
 
Hrg1 
1).  Hrg1 is duplicated in the zebrafish genome.  Two ohnologues (paralogs) are found, hrg1a 
(slc48a1b) and hrg1b (slc48a1a).  Hrg1a and Hrg1b are functional orthologs to worm, mouse 
and human HRG1, with similar topology comprising of four transmembrane domains, 
cytoplasmic N- and C-terminus.  Expression of Hrg1a and Hrg1b can ameliorate the growth 
of a heme-deficient yeast strain upon heme supplementation.   
 
2).  Hrg1a and hrg1b are widely expressed throughout the zebrafish embryo and both 
mRNAs are maternally deposited during oogenesis.  RT-PCR reveals that hrg1a and hrg1b 
mRNA are expressed in various adult tissues including the kidney and spleen, the major 
hematopoietic organs in zebrafish.  Expression of fluorescence-tagged Hrg1a and Hrg1b 
proteins in mammalian cells reveals that Hrg1a and Hrg1b localize to the endo-lysosomal 






3).  Injection of hrg1a_I2E3_MO2 morpholino into zebrafish embryos causes severe anemia 
in addition to morphological defects, even though hrg1a mRNA was only partially affected.  
However,  knockdown of hrg1a or hrg1b with other morpholinos did not result in severe 
anemia.   
 
4).  Hrg1aiq261/iq261; hrg1biq361/iq361 zebrafish mutants generated by CRISPR/Cas9 show no 
detectable Hrg1 proteins and double mutant embryos show no hematological defects.  
Knockdown of hrg1a in hrg1b mutants or vice versa do not impair erythropoiesis in zebrafish 
embryos.  These genetic studies suggest that Hrg1 is not required for primitive erythropoietic 
development in zebrafish embryos. 
 
5).  The anemic phenotypes of hrg1a_I2E3_MO2 morpholino cannot recapitulate the genetic 
muants in hrg1.  Thus, the morpholino phenotype could be due to a dominant negative affect 
of the mis-spliced mRNA product or or an off-target effect. 
 
6).  Zebrafish RES is responsible for clearing damaged RBCs and for recycling heme-iron 
under hemolytic conditions.  Hrg1a and hrg1b mRNA are upregulated in the zebrafish spleen 
and kidney upon PHZ-induced hemolysis, concomitant with hmox1, a heme-degrading 
enzyme essential for heme-iron recycling. 
 
7).  Whole transcriptome sequencing of mRNA extracted from the spleen and kidney reveals 
significant differentially expressed genes in immune response, lipid transport, oxidation-
reduction processes, and proteolysis.  This result indicates that hrg1aiq261/iq261; hrg1biq361/iq361 







8).  qRT-PCR on mRNA from kidneys and spleens of adult zebrafish at 1 day post-PHZ 
treatment reveal no significant differences in hmox1 induction between double heterozygotes 
(Hets), single mutants (hrg1aiq261/iq261 and hrg1biq361/iq361), and double mutants (hrg1aiq261/iq261; 
hrg1biq361/iq361); a noticeable trend was observed for hmox1 mRNA, which was lower in the 
double mutants.  Perl’s histochemical staining for iron reveal that iron is mis-localized to 
renal tubules in hrg1 double mutants compared to WT kidney, which reveals iron 
accumulation mainly in macrophages.   
 
Mrp5 
1).  Zebrafish Mrp5/Abcc5 encodes a 1,426 aa protein with twelve transmembrane and two 
NBD domains.  Zebrafish Mrp5 shows ~32% homology to C. elegans MRP-5 and ~74% 
homology to mammalian MRP5.  Expression of Mrp5 worsens the growth of heme-deficient 
hem1∆ mutant yeast, similar to C. elegans MRP-5, indicating that these Mrp5 proteins may 
serve similar functions as heme exporters. 
 
2).  Zebrafish mrp5 mRNA is ubiquitously expressed throughout the zebrafish embryo and is 
detectable at ~18 hpf.  Morpholino knockdown of mrp5 results in severe anemia and 
developmental defects, which can be specifically rescued by co-injection with recoded 
zebrafish mrp5 cRNA.  Reduced expression of the erythropoietic-specific transcription factor 
gata1 in 1 dpf mrp5 morphant embryos indicate that Mrp5 is required for differentiation of 
RBCs.  Accordingly, the number of RBCs was lower in 3 dpf mrp5 morphants.  While the 
mechanism whereby loss of mrp5 results in anemia remains unknown, these results indicate 
that Mrp5 plays a role in regulating heme homeostasis and erythropoiesis. 
 
3).  Zebrafish Mrp9/Abcc12 encodes a 1,368 aa protein with twelve transmembrane and two 





homolog to Mrp5 in the zebrafish genome.  Expression of Mrp9 in the hem1∆ yeast mutant 
shows reduced growth indicating that Mrp9 may have similar function as Mrp5. 
 
4).  Zebrafish mrp9 is expressed throughout the embryo including at the one-cell stage 
suggesting that mrp9 mRNA is maternally deposited during oogenesis.  Knockdown of mrp9 
by both translation- and splice-blocking morpholinos results in less o-dianisidine staining of 
embryos.  These results indicate that Mrp9 may be involved in the early development of 
RBCs in the zebrafish embryos.  However, whether Mrp9 and Mrp5 functions synergistically 
or independently is unclear.   
 
Future Directions 
Localization of Hrg1 in RES of adult zebrafish 
While qRT-PCR revealed that hrg1a and hrg1b mRNA are both expressed in zebrafish 
RES and upregulated during PHZ-induced hemolysis, localization of Hrg1a and Hrg1b 
proteins in the tissue context needs to be addressed especially in macrophages.  We have tried 
to generate transgenic zebrafish with Hrg1a and Hrg1b tagged with fluorescent proteins using 
BAC (Bacterial Artificial chromosome) transgenesis.  However, owing to the low efficiency 
and possible position effects by random insertion of the transgene, we did not successfully 
obtain a transgenic line with strong transgene expression.  Our lab has generated custom 
HRG1 antibodies using the C-terminus 17-aa from human HRG1 as the immunogen.  
Although the customized HRG1 antibody can recognize zebrafish Hrg1, IHC 
(immunohistochemistry) staining in zebrafish sections with HRG1 antibody showed high 
background staining.  To overcome this technical hurdle, we can adopt CRISPR/Cas9 
technology to generate transgenic zebrafish by inserting GFP into the hrg1a or hrg1b 





fusion (6).  We have successfully used this strategy to generate a HRG1::GFP mouse.  These 
transgenic Hrg1::GFP fish can then be used to check the localization of Hrg1a and Hrg1b 
protein using intra-vital imaging and co-localizing the protein either with IHC or genetic 
crosses with other transgenic zebrafish expressing fluorescent-tagged macrophage or other 
hematopoietic lineage markers (below).  We can also perform flow cytometry with the 
transgenic fish to analyze the expression of Hrg1 in hematopoietic tissues and erythroid cells.  
Moreover, if we obtain the translational fusions with Hrg1a::GFP or Hrg1b::mCherry, we can 
intercross them to obtain double transgenic fish in which we can evaluate the biological role 
of both Hrg1 proteins concurrently. 
 
Generating transgenic fish with hematopoietic markers in hrg1 mutants 
The transparency of the zebrafish embryo facilitates label-free visualization of cellular 
components in intact embryos.  To better characterize hrg1 mutant zebrafish, we can cross 
the established transgenic fish with hematopoietic lineages marked with fluorescent tags, 
such as globinLCR: GFP for RBCs; gata1: GFP for erythropoietic progenitor cells; and 
mpeg1: GFP for macrophages, to hrg1a and hrg1b double mutant.  Flow cytometry analysis 
can be performed to check the expression profiles of these markers in hrg1 mutants (154).  
Additionally, we can specifically quantify the hematopoietic cell profiles by FACS analysis 
of adult kidney, the major hematopoietic tissue for zebrafish, in hrg1 mutants (183). 
 
Histological staining of heme and iron  
We propose that hrg1 mutant zebrafish may have a defect in heme-iron recycling in 
RES macrophage.  We can perform histological staining to examine the potential heme or 






Iron restriction diets in zebrafish  
In human, heme-iron recycling from senescent RBCs contributes to more than 90% of 
daily iron requirement, while dietary iron accounts for the remaining 10% (5, 6).  This is in 
stark contrast to the well-studied mouse model which relies equally on dietary iron absorption 
and macrophage heme-iron recycling.  The individual contribution of iron/heme absorption 
versus recycling is poorly understood in teleosts. The zebrafish is typically fed a diet of brine 
shrimp and dry food extracts everyday which is likely to be iron-loaded.  Indeed, a typical 
mouse is fed chow containing 200 ppm of iron which is at least 10 times more than what is 
required for normal growth and development.  Therefore, one possible explanation for why 
the hrg1 mutants lack overt hematopoietic phenotypes could be because zebrafish can obtain 
sufficient iron from dietary absorption, or plausibly through its gills to overcome a block in 
heme-iron recycling by the RES macrophages (184).  Few studies have been published to 
date on how to iron-restrict zebrafish.  One way would be to formulate a custom fish diet with 
low iron and heme to limit dietary iron, in addition to restricting iron in the water by 
supplementing the water with a non-toxic iron chelator.  If Hrg1 is the major heme-iron 
transporter, we may be able to tease-out the specific contribution of Hrg1 using these 
strategies.   
 
Functional characterization of Hrg1 interacting proteins 
The long-term goals of our laboratory are to identify potential components in 
eukaryotic heme trafficking network.  One way to identify components in HRG1-dependent 
heme trafficking pathway is to analyze interacting proteins that co-immunoprecipitate with 
HRG1 by multidimensional protein identification technology (MudPIT) using a defined 
mammalian cell culture system.  Once these interactors are identified, they need to be further 





zebrafish can be exploited to define the in vivo requirements of these interacting proteins by 
assessing their temporospatial expression and the effect of gene knockdowns in zebrafish 
embryos to assess synthetic or interacting phenotypes.  CRISPR/Cas9 can be used to generate 
mutants for the most credible HRG1-interacting protein(s). 
 
Generation and characterization of mrp5/mrp9 mutants zebrafish 
We have used CRISPR/Cas9 to generate mrp5 and mrp9 mutant zebrafish.  Ian 
Chambers, a graduate student in our laboratory, is currently genotyping and screening to 
retrieve null alleles of mrp5 and mrp9 in zebrafish.  He has genotyped F0 founder fish 
containing mrp5 and mrp9 mutations and is in the process of generating mrp5; mrp9 double 
mutants.  Future work with mutant zebrafish will determine the role of Mrp5/Mrp9 in 
maternal-fetal nutrient heme transfer, embryonic development, and differentiation of 
erythroid cells in zebrafish.  Moreover, all the proposed experiments for Hrg1 delinated 
above are also applicable for characterizing Mrp5 and Mrp9. 
 
Genetic pathway analysis with Hrg1 and Mrp5/Mrp9 
Hrg1 and Mrp5 are identified as heme importer and exporter respectively.  To 
genetically delineate the functional relationship of Hrg1 and Mrp5/Mrp9, we can morpholino 
knockdown hrg1 in mrp5/mrp9 transgenic fish to examine the alternation of mrp5 and mrp9 
expression, or vice versa since it will be technically challenging and time-consuming to 
generate a quadruple knockout i.e. hrg1a; hrg1b; mrp5; mrp9 mutant. 
 
Interrogating heme trafficking in zebrafish by heme-sensors 
One advantage of the zebrafish embryos is the ex utero transparency of early stage 





APX (ascorbate peroxidase)-based subcellular probes, and genetically-encoded fluorescent 
sensors to interrogate the intra- and inter- cellular heme trafficking (185, 186).  We can 
generate transgenic zebrafish expressing these heme sensors/reporters to directly visualize 
heme trafficking in the transparent embryos at the maternal-embryonic interface and between 
tissues and organs.   
 
Significance 
The current paradigm dictates that erythroblasts are self-sufficient, i.e. they produce 
large amounts of hemoglobin by simply upregulating endogenous heme synthesis.  However, 
terminal erythroid maturation includes loss of intracellular organelles including mitochondria, 
the site for heme synthesis.  Therefore, exogenous heme uptake may compensate for loss of 
heme synthesis in the maturing red cell.  We postulate that during this terminal maturation, 
erythroid cells import exogenous heme through Hrg1, to maxmize hemoglobin production 
during RBCs maturation.  It is possible that a portion of heme within maturing RBCs is 
derived from inter-cellular transport from nurse macrophages in EBIs to support the 
continuing hemoglobinization of RBCs, especially under conditions such as stress 
erythropoiesis.  Understanding how Hrg1 is involved in the terminal RBC maturation may 
shed light on anemia. 
Majority of the daily iron needs are fulfilled by heme-iron recycling via RES 
macrophages.  Deficiency in heme-iron recycling concomitantly results in heme 
accumulation in macrophages and iron deficiency, as revealed by hmox1-/- mice, a heme 
degrading enzyme which functions downstream of hrg1 during heme-iron recycling through 
EP (86).  Moreover, transplantation of WT macrophage in hmox1-/- mice corrects the 
phenotypes (187).  As heme accumulation is toxic and can be pro-inflammatory, blocking 
Hrg1-mediated heme transport upstream from Hmox1 may prove to be an effective 





Additionally, heme export by MRP5 is conserved among metazoans.  Knockdown of 
Mrp5 in zebrafish embryos results in developmental defects and decreased RBCs formation.  
Previous studies revealed that Flvcr1, a heme exporter, is required for cell survival and 
development of erythroid progenitors (53, 143).  We envisage that cellular heme levels are 
maintained by a combination of heme export and heme degradation.  Thus, understanding 
pathways of inter- and intra-cellular heme export may be relevant to specific conditions of 










Sequences of morpholinos 
Morpholino Name Sequence 
hrg1a_ATG_MO 5'-ATACGTCTTATTGAACGCCATTCCT  -3' 
hrg1a_E2I2_MO1 5'-CAGCCAAGGAATTACCTGATAATC -3' 
hrg1a_I2E3_MO2 5'-CCATAATGCCAAAACTCCTGAAAAA  -3' 
hrg1b_ATG_MO 5'-GTAGATCCTGTTTGGACCCATTGAT  -3' 
hrg1b_E2I2_MO 5'-CCGTCAATGTCAAAGTACTCACACT  -3' 
hrg1b_I1E2_MO2 5'-CCAGAGCGCCAGGACTCCTGTAGAT -3' 
Mrp5_ATG_MO 5'-CCCAAATCATGTCCTTTCATCTTCT -3' 
Mrp5_E26_MO 5'-ACATGGATTTTGACTCACCTTGCAC  -3' 
Abcc12_ATG_MO 5'-GGGAAGTCCTTCATTTTTACTATAG -3' 
Abcc12_E29_MO 5'-TTGTGTTTTTACTTTGGAGTTGCGC -3' 
alas2_MO 5'-CAGTGATGCAGAAAAGCAGACATGA -3' 
p53_MO 5'- GCGCCATTGCTTTGCAAGAATTG -3' 






















Hrg1b-Probe_BamHI_Rev GATCTCGGATCC GACTTAAACTGTATATTATTTCC 
MRP5_Probe_SalI_Fwd TTCCTCCAGTCGACAGGCTGACGGCGTACTTCAG 





zfβ-actin For TGTTTTCCCCTCCATTGTTGG 
zfβ-actin Rev TTCTCCTTGATGTCACGGAC 
Cbfb F1 CGGATCAGAGGAGCAAGTTC 















zfef1a_qPCR_Fwd GAG AAG TTC GAG AAG GAA GC 




















































































Genotyping primers of hrg1a and hrg1b mutants  
Genotyping Primers Sequence 
zf1a_TALE1&2_fwd_PstI_1(Exon2) 




GAA TTA TCA AGC TT 
CACATCACAGGCTCTTTCCGAG 
zfhrg1a_PstI_TAL_E3_fwd(Exon3) 
AAG CTA CAC TGC AG 
CAGAGATGTGTTTGCTTATTGTGTG 
zfhrg1a_HindIII_TAL_E3_rev(Exon3) 
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